From owner-sci-resources@net.bio.net Mon Feb 05 22:00:00 1996
Path: biosci!biosci!not-for-mail
From: BIOSCI Administrator <biosci-help@net.bio.net>
Newsgroups: bionet.sci-resources
Subject: NSF - Summary of new documents on STIS, 4 Febrary 1996
Date: 6 Feb 1996 12:08:16 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 73
Sender: daemon@net.bio.net
Approved: biosci-help@net.bio.net
Distribution: world
Message-ID: <4f8cfg$89l@net.bio.net>
NNTP-Posting-Host: net.bio.net

This message contains a summary of the documents added to the NSF STIS
system in the previous week.  Reference material concerning STIS
follows the summary.
------------------------------------------------------------------------
                     ** NEW DOCUMENTS ON STIS **

Document Type: Program Guideline

   Title: NSF 96-40  Dear Colleague Letter
               File size (bytes):       
               STIS Filename:           nsf9640.txt

Document Type: Recruit

   Title: Physical Science Administrator (Lower Atmospheric
          Observing Facilities Manager)
               File size (bytes):       
               STIS Filename:           vex969.txt

------------------------------------------------------------------------
                ** UPDATES TO EXISTING STIS DOCUMENTS **

Document Type: Phone Book

   Title: NSF Alpha Telephone Directory
               File size (bytes):       113194
               STIS Filename:           phnalpha.txt
               Also available:          phnalpha.dlm

   Title: NSF Organization Telephone Directory
               File size (bytes):       125281
               STIS Filename:           phnorg.txt

------------------------------------------------------------------------
                       ** FOR YOUR REFERENCE **
------------------------------------------------------------------------
HOW TO OBTAIN DOCUMENTS

The above files can be retrieved in electronic form using the STIS
system.  If you don't know how to use STIS, send an E-mail message to
stisinfo@nsf.gov (Internet).  You will receive
a copy of the STIS flyer via E-mail.

If you are already using STIS, you can use the information above to
retrieve these files:

Documents via E-mail:

     Send a message to stisserve@nsf.gov (Internet).
     Use the "STIS Filename" shown above in the "get" command.
     For example, to retrieve phnorg.txt, the text of your message should be 
     as follows:
                       get phnorg.txt

Anonymous FTP:

     FTP to stis.nsf.gov.  Use the "STIS Filename" shown above to
     retrieve a file.  For example, to retrieve phnorg.txt, you would
     enter:
                       ftp> get phnorg.txt

WAIS or Gopher:

     Do a word search on the filename as shown in the summary.

If you want a *printed* copy of a document:

     Send your name and postal mailing address, and the document title
     and number to "pubs@nsf.gov" (Internet).

If you have problems with the above procedures:

     Send a message to "stis@nsf.gov" (Internet).

From owner-sci-resources@net.bio.net Thu Feb 08 22:00:00 1996
Path: biosci!biosci!not-for-mail
From: kcowing@aibs.org (Keith L. Cowing)
Newsgroups: bionet.sci-resources
Subject: NASA Space Life Science Proposal Solicitation
Date: 8 Feb 1996 20:34:36 -0800
Organization: American Institute of Biological Sciences
Lines: 58
Sender: daemon@net.bio.net
Approved: biosci-help@net.bio.net
Distribution: world
Message-ID: <4feiss$3ui@net.bio.net>
NNTP-Posting-Host: net.bio.net

COMMERCE BUSINESS DAILY ISSUE OF FEBRUARY 7,1996
 
 A -- RESEARCH OPPORTUNITIES IN SPACE LIFE SCIENCES 
SOL NRA-96-OLMSA-O1A 
DUE 051596 
POC Dr. Ronald J. White tel: 202/358-2530  

The National Aeronautics and Space Administration (NASA) Life Sciences 
Division solicits proposals to participate in research opportunities  in
space life sciences and in research and development opportunities  in
advanced life support and environmental technologies for Human Exploration
and Development of Space. This solicitation is open to  U.S. and foreign
proposers in all categories of Governmental and private sector
organizations, agencies, and institutions. It will be  open for the period
through May 15, 1996; proposals may be submitted  at any time throughout
the period. This solicitation is available  electronically via the
Internet at http://peer1.idi.usra.edu/. Paper  copies of the Announcement
are available to those who do not have  access to the Internet by calling
202-358-4180. Specific questions  concerning this annoucement should be
directed to: Ms. Victoria Thorne, Life Sciences Division, Code UL, NASA
Headquarters, Washington, DC 20546-0001; telephone (202) 358-2530, email:
vthorne@gm.olmsa.hq.nasa.gov. (0036)



COMMERCE BUSINESS DAILY ISSUE OF FEBRUARY 7,1996 

A -- ADV. LIFE SUPPT & ENVIRON. TECH. FOR HUMAN EXPLOR. & DEVELOP. OF  SPACE 
SOL NRA-96-OLMSA-01B 
DUE 051596 
POC Dr. Ronald J. White tel: 202/358-2530 

ADVANCED LIFE SUPPORT AND ENVIRONMENTAL TECHNOLOGIES FOR  HUMAN
EXPLORATION AND DEVELOPMENT OF SPACE. 

The National Aeronautics  and Space Administration (NASA) Life Sciences
Division solicits proposals to participate in research opportunities in
space life sciences and in research and development opportunities in
advanced  life support and environmental technologies for Human
Exploration and  Development of Space. This solicitation is open to U.S.
and foreign  proposers in all categories of Governmental and private
sector organizations, agencies, and institutions. It will be open for the 
period through May 15, 1996; proposals may be submitted at any time 
throughout the period. This solicitation is available electronically  via
the Internet at http://peer1.idi.usra.edu/. Paper copies of the 
Announcement are available to those who do not have access to the 
Internet by calling 202-358-4180. Specific questions concerning this
announcement should be directed to: Ms. Victoria Thorne, Life Sciences 
Division, Code UL, NASA Headquarters, Washington, DC 20546-0001; 
telephone (202) 358-2530, email: vthorne@gm.olmsa.hq.nasa.gov. (0036)

-- 
Keith L. Cowing  -  Manager of Planning and Operations
American Institute of Biological Sciences
10700 Parkridge Blvd Suite 380  -  Reston, VA, USA 22091
703-758-1212 voice  -  703-758-1222 fax
kcowing@aibs.org  -  gopher://aibs.org


From owner-sci-resources@net.bio.net Thu Feb 08 22:00:00 1996
Path: biosci!biosci!not-for-mail
From: "Marvin.Stodolsky" <Marvin.Stodolsky@mailgw.er.doe.gov>
Newsgroups: bionet.sci-resources
Subject: DOE Human Genome Program Announcement  R&D
Date: 8 Feb 1996 20:49:19 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 123
Sender: daemon@net.bio.net
Approved: biosci-help@net.bio.net
Distribution: world
Message-ID: <4fejof$61s@net.bio.net>
NNTP-Posting-Host: net.bio.net

                         Office of Energy Research

                                Notice 96-08
               Human Genome Program - Technological Advances

DEPARTMENT OF ENERGY
OFFICE OF ENERGY RESEARCH

Energy Research Financial Assistance Program Notice 96-08: Human Genome
Program - Technological Advances

AGENCY: U.S. Department of Energy (DOE)

ACTION: Notice inviting grant applications

SUMMARY: The Office of Health and Environmental Research (OHER) of the
Office of Energy Research (ER), U.S. Department of Energy, hereby announces
its interest in receiving grant applications in support of the DOE Human
Genome Program (HGP). This program is a coordinated, multidisciplinary,
goal-oriented research effort to obtain a detailed understanding of the
human genome at the molecular level. The objective of this notice is to
promote substantive improvements in high-throughput, integrated approaches
to large-scale human genome sequencing and its analysis. The solicited
topics are: (1) supportive instrumentation and automation systems; (2)
assembly of multi-megabase scale, ordered and sequence-ready DNA clones;
(3) informatics for the rapid assembly, analysis, and annotation of data
from high-throughput sequencing; and (4) informatics for facile submission,
retrieval, and visualization of data for single or multiple related
databases, specifically including the Genome Data Base and the Genome
Sequence Data Base. Applicants must address clearly how the proposed work
will help achieve the sequencing goals of the HGP. Collaborative,
multidisciplinary efforts are specifically encouraged.

DATES: Potential applicants are strongly encouraged to submit a brief
preapplication. All preapplications, referencing Program Notice 96-08,
should be received by DOE by 4:30 P.M. E.S.T., March 28, 1996. A response
discussing the potential program relevance of a formal application
generally will be communicated to the applicant within 30 days of receipt.
The deadline for receipt of formal applications submitted in response to
this notice must be received by 4:30 p.m., E.D.T., July 11, 1996, in order
to be accepted for merit review in September 1996 and to permit timely
consideration for awards in fiscal year 1997.

ADDRESSES: All preapplications, referencing Program Notice 96-08, should be
sent to Ms. Joanne Corcoran, U.S. Department of Energy, Office of Health
and Environmental Research, ER-72, 19901 Germantown Road, Germantown, MD
20874- 1290.

After receiving notification from DOE concerning successful
preapplications, applicants may prepare formal applications and send them
to: U.S. Department of Energy, Office of Energy Research, Grants and
Contracts Division, ER-64, 19901 Germantown Road, Germantown, MD
20874-1290, ATTN: Program Notice 96-08. The above address for formal
applications also must be used when submitting formal applications by U.S.
Postal Service Express Mail, any commercial mail delivery service, or when
handcarried by the applicant.

FOR FURTHER INFORMATION CONTACT: Dr. Gerald Goldstein, if referencing topic
(1); Dr. Marvin Stodolsky, if referencing topic (2); and Dr. Jay Snoddy, if
referencing topics (3) or (4) at the U.S. Department of Energy, Office of
Health and Environmental Research, ER-72, 19901 Germantown Road,
Germantown, MD 20874-1290, by telephone (301) 903-6488, by facsimile (301)
903-8521, or preferably by E-mail, joanne.corcoran@oer.doe.gov. General HGP
information can also be obtained on the World Wide Web (WWW) Internet
browsers at: http://www.er.doe.gov/production/oher/hug_top.html,
http://www.ornl.gov/techresources/human_genome/home.html, and sites linked
to these WWW pages. The 5-year goals of the U.S. HGP are published in the
journal, Science, volume 262, pages 43-46.

SUPPLEMENTARY INFORMATION: The brief preapplication, in accordance with 10
CFR 600.10(d)(2), should consist of two to three pages of narrative
describing the research objectives and methods of accomplishment. The
preapplications will be reviewed for relevance to the notice, and further
instructions will be provided with the response. Preapplications determined
by staff of the Office of Health and Environmental Research to be
insufficiently directed at the goals of this notice will be returned
without further review to the applicant. Telephone and FAX numbers are
required parts of the preapplication, and electronic mail addresses are
desirable.

It is anticipated that approximately $2,000,000 will be available for grant
awards in this area during FY 1997, contingent upon availability of
appropriated funds. Multiple year funding of grant awards is expected, and
is also contingent upon availability of funds, progress of the research,
and continuing program need. Projected awards will be in the range of
$50,000 per year up to $1,000,000 per year with terms of 2 to 3 years.

Information on the development and submission of applications, eligibility,
limitations, evaluation, selection process, and other policies and
procedures may be found in 10 CFR Part 605, and in the Application Guide
for the Office of Energy Research Financial Assistance Program. The
Application Guide is available from the U.S. Department of Energy, Office
of Health and Environmental Research, Health Effects and Life Sciences
Research Division, ER-72, 19901 Germantown Road, Germantown, MD 20874-1290.
Telephone requests may be made by calling (301) 903-6488. Internet requests
can be made to: joanne.corcoran@oer.doe.gov. Electronic access to ER's
Financial Assistance Guide is possible via the Internet using the following
E- mail address: http://www.er.doe.gov

The Office of Energy Research, as part of its grant regulations, requires
at 10 CFR 605.11(b) that a grantee funded by ER and performing research
involving recombinant DNA molecules and/or organisms and viruses containing
recombinant DNA molecules shall comply with the National Institutes of
Health "Guidelines for Research Involving Recombinant DNA Molecules" (59 FR
34496, July 5, 1994) or such later revision of those guidelines as may be
published in the Federal Register.

The Catalog of Federal Domestic Assistance Number for this program is
81.049, and the solicitation control number is ERFAP 10 CFR part 605.

Issued in Washington, D.C.

John Rodney Clark
Associate Director
for Resource Management
Office of Energy Research

Published in the Federal Register February 7, 1996, Vol. 61, No. 26,
pages 4630-4631.
-----------------------------
This document is also available as at:
     http://www.er.doe.gov/production/grants/fr96_08.html


From owner-sci-resources@net.bio.net Thu Feb 08 22:00:00 1996
Path: biosci!biosci!not-for-mail
From: "Marvin.Stodolsky" <Marvin.Stodolsky@mailgw.er.doe.gov>
Newsgroups: bionet.sci-resources
Subject: DOE Human Genome Program Announcement,  ELSI
Date: 8 Feb 1996 20:50:06 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 185
Sender: daemon@net.bio.net
Approved: biosci-help@net.bio.net
Distribution: world
Message-ID: <4fejpu$648@net.bio.net>
NNTP-Posting-Host: net.bio.net

                         Office of Energy Research

                                Notice 96-09
                           Human Genome Program -
                  Ethical, Legal, and Social Implications

DEPARTMENT OF ENERGY
OFFICE OF ENERGY RESEARCH

Energy Research Financial Assistance Program Notice 96-09: Human Genome
Program - Ethical, Legal, and Social Implications

AGENCY: U.S. Department of Energy (DOE)

ACTION: Notice inviting grant applications.

SUMMARY: The Office of Health and Environmental Research (OHER) of the
Office of Energy Research (ER), U.S. Department of Energy, hereby announces
its interest in receiving applications in support of the Ethical, Legal,
and Social Implications (ELSI) subprogram of the Human Genome Program
(HGP). This program is a coordinated, multidisciplinary, directed research
effort aimed at obtaining a detailed understanding of the human genome at
the molecular level. This particular research notice encompasses research
grants that address ethical, legal, and social issues that may arise from
the use of information and knowledge resulting from the HGP.

DATES: Potential applicants are strongly encouraged to submit a brief
preapplication. All preapplications referencing Program Notice 96-09,
should be received by DOE by 4:30 P.M. E.S.T., March 28, 1996. A response
discussing the potential program relevance of a formal application
generally will be communicated to the applicant within 30 days of receipt.
The deadline for receipt of formal applications submitted in response to
this notice must be received by 4:30 p.m., E.D.T., July 11, 1996, to be
accepted for merit review in September 1996 and to permit timely
consideration for award in fiscal year 1997.

ADDRESSES: Preapplications referencing Program Notice 96-09 should be sent
to Dr. Daniel W. Drell, U.S. Department of Energy, Office of Health and
Environmental Research, ER-72, 19901 Germantown Road, Germantown, MD
20874-1290.

After receiving notification from DOE concerning successful
preapplications, applicants may prepare formal applications and send them
to: U.S. Department of Energy, Office of Energy Research, Grants and
Contracts Division, ER-64, 19901 Germantown Road, Germantown, MD,
20874-1290, ATTN: Program Notice 96-09. The above address for formal
applications also must be used when submitting formal applications by U.S.
Postal Service Express Mail, and commercial mail delivery service, or when
handcarried by the applicant.

FOR FURTHER INFORMATION CONTACT: Dr. Daniel W. Drell, U.S. Department of
Energy, Office of Health and Environmental Research, ER-72, 19901
Germantown Road, Germantown, MD 20874-1290, by telephone (301) 903-6488, by
FAX (301) 903-8521, or preferably by E-mail, joanne.corcoran@oer.doe.gov.

SUPPLEMENTARY INFORMATION: The DOE encourages the submission of
applications to conduct research on privacy and confidentiality issues from
the creation, use, maintenance, and disclosure of genetic information. This
may include (but is not limited to) issues of ownership, commercialization,
and control of genetic information, and the protection of the privacy of
genetic information in various settings, including the workplace.
Applications should demonstrate knowledge of the relevant literature and
should include detailed plans for the gathering and analysis of factual
information and the associated ethical, legal, and social implications. All
applications should include, where appropriate, detailed discussion of
human subjects protection issues, e.g., storage of, manipulation of, and
access to data. Provisions to ensure the inclusion of women, minorities,
and potentially disabled individuals must be described, unless specific
exclusions are scientifically necessary and justified in detail. All
proposed research applications should address the issue of efficient
dissemination of results to the widest appropriate audience. All
applications involving collaborations should include letters of support
from the potential collaborators; these letters should specify the
contributions the collaborator intends to make if the application is
accepted and funded.

The DOE also solicits applications for the preparation and dissemination of
educational materials in any appropriate medium that will enhance
understanding of scientific, as well as the ethical, legal, and social
aspects of the HGP among public or specified groups. If an educational
effort for a specific group is proposed, the value to the HGP of that group
or community should be explained in detail. In addition, the DOE encourages
applications for the support of conferences focusing on the ethical, legal,
and social implications of the HGP. Issues to be examined may include (but
are not limited to) implications of advances in the genetic
characterization of complex traits (e.g., disease predisposition or
susceptibility genes) and the impacts of advances in knowledge about
polygenic conditions for various communities potentially faced with these
impacts (e.g., courts, schools, etc.).

Educational and conference applications should demonstrate awareness of the
relevant literature and include detailed plans for the accomplishment of
project goals. In applications that propose the production of series for
broadcast, audio-visuals, or other educational materials, the DOE requests
that samples of previous similar work by the producers and writers be
submitted along with the application. In applications for the support of
educational activities, the DOE requests inclusion of a plan for assessment
of the effectiveness of the proposed activities. For conference
applications, a detailed and largely complete roster of speakers is
necessary. At the completion of the conference, a summary or report is
required. Educational and conference applications must also demonstrate
awareness of the need to reach the widest appropriate audience.

Ordinarily, DOE does not encourage applications dealing with issues
consequent to genetic testing protocols. Additionally, DOE does not
encourage survey-based research, unless a compelling case is made that this
methodology is critical to address an issue of uncommon significance. For
applications that propose the development of college-level curricula, DOE
requests both detailed justification of the need for external support
beyond normal departmental and college resources, evidence of commitment
from the parent department or college, and a dissemination plan.
Applications for the writing of scholarly publications or books should
include justifications for the relevance of the publications or book to the
goals of the HGP as well as discussion of the estimated readership and
impact. DOE ordinarily will not provide unlimited support for a funded
program and, thus, strongly encourages the inclusion of plans for
transition to self-sustaining status.

The brief preapplication, in accordance with 10 CFR 600.10(d)(2), should
consist of two to three pages of narrative describing the research project
objectives and methods of accomplishment. The preapplications will be
reviewed for relevance to the notice, and further instructions will be
provided with the response. Preapplications determined by staff of the
Office of Health and Environmental Research to be insufficiently directed
at the goals of the notice will be returned without further review to the
applicant. Telephone and facsimile numbers are required parts of the
preapplication, and electronic mail addresses are desirable.

It is anticipated that approximately $1,300,000 will be available for grant
awards in this area during FY 1997, contingent upon availability of
appropriated funds. Multiple year funding of grant awards is expected, and
is also contingent upon availability of funds. Previous awards have ranged
from $50,000 per year up to $500,000 per year with terms from 1 to 3 years;
most awards average about $200,000 per year for 2 or 3 years. Similar award
sizes are anticipated for new grants.

Information about development and submission of applications, eligibility,
limitations, evaluation, selection process, and other policies and
procedures may be found in 10 CFR Part 605, and in the Application Guide
for the Office of Energy Research Financial Assistance Program. The
Application Guide is available from the U.S. Department of Energy, Office
of Health and Environmental Research, Health Effects and Life Sciences
Research Division, ER-72, 19901 Germantown Road, Germantown, MD 20874-1290.
Telephone requests may be made by calling (301) 903-6488. Internet requests
can be made to: joanne.corcoran@oer.doe.gov. Electronic access to ER's
Financial Assistance Guide is possible via the Internet using the following
E- mail address: http//www.er.doe.gov

The Office of Energy Research, as part of its grant regulations, requires
at 10 CFR 605.11(b) that a grantee funded by ER and performing research
involving recombinant DNA molecules and/or organisms and viruses containing
recombinant DNA molecules shall comply with the National Institutes of
Health "Guidelines for Research Involving Recombinant DNA Molecules" (59 FR
34496, July 5, 1994), or such later revision of those guidelines as may be
published in the Federal Register.

The dissemination of materials and research data in a timely manner is
essential for progress towards the goals of the DOE HGP. The OHER requires
the timely sharing of resources and data. Applicants should, in their
applications, discuss their plans for disseminating research results and
materials that may include, where appropriate, publication in the open
literature, wide-scale mailings, etc. Once OHER and the applicant have
agreed upon a distribution plan, it will become part of the award
conditions. Funds to defray the costs of disseminating results and
materials are allowable; however, such requests must be sufficiently
detailed and adequately justified. Applicants should also provide timelines
projecting progress toward achieving proposed goals.

The Catalog of Federal Domestic Assistance Number for this program is
81.049, and the solicitation control number is ERFAP 10 CFR part 605.

Issued in Washington, D.C.

John Rodney Clark
Assoicate Director
for Resource Management
Office of Energy Research

Published in the Federal Register February 7, 1996, Vol. 61, No. 26,
pages 4631-4633.

-----------------------------
This announcement is also available at:
     http://www.er.doe.gov/production/grants/fr96_09.html


From owner-sci-resources@net.bio.net Mon Feb 12 22:00:00 1996
Path: biosci!biosci!not-for-mail
From: BIOSCI Administrator <biosci-help@net.bio.net>
Newsgroups: bionet.sci-resources
Subject: NSF - Summary of new documents on STIS, 11 February 1996
Date: 12 Feb 1996 22:45:53 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 154
Sender: daemon@net.bio.net
Approved: biosci-help@net.bio.net
Distribution: world
Message-ID: <4fpc31$d4k@net.bio.net>
NNTP-Posting-Host: net.bio.net

This message contains a summary of the documents added to the NSF STIS
system in the previous week.  Reference material concerning STIS
follows the summary.
------------------------------------------------------------------------
                     ** NEW DOCUMENTS ON STIS **

Document Type: News

   Title: Media Tipsheet February 5, 1996
               File size (bytes):       
               STIS Filename:           tip60203.txt

Document Type: Press Release

   Title: CAREER GRANTS INTEGRATE TEACHING AND RESEARCH
               File size (bytes):       
               STIS Filename:           pr965.txt

   Title: "LASER TWEEZER" TECHNIQUE MEASURES DNA "MECHANICS"
               File size (bytes):       
               STIS Filename:           pr966.txt

Document Type: Recruit

   Title: VEP 96000 Assistant Director for Social, Behavioral, and
          Economic Sciences (SBE)
               File size (bytes):       5523
               STIS Filename:           vep96000.txt

------------------------------------------------------------------------
                ** UPDATES TO EXISTING STIS DOCUMENTS **

Document Type: Committees

   Title: NSF Advisory Committee Meetings
               File size (bytes):       9328
               STIS Filename:           cmmtg.txt

Document Type: International Document

   Title: INT 96-02 - STATUS ON RESEARCH AND PRODUCTION PRACTICES IN
          INDUSTRIAL MACHINERY AND MACHINE TOOLS INDUSTRY IN JAPAN
               File size (bytes):       25184
               STIS Filename:           int9602.txt
               Also available:          int9602.doc

   Title: INT 96-03 . Emerging Manufacturing Technologies and
          Research Activities in Japan
               File size (bytes):       23750
               STIS Filename:           int9603.txt
               Also available:          int9603.doc

Document Type: Letter

   Title: Current List of REU Sites
               File size (bytes):       83906
               STIS Filename:           reulist.txt

Document Type: News

   Title: Geometry and Cosmology
               File size (bytes):       1173
               STIS Filename:           mpslect.txt

Document Type: Phone Book

   Title: NSF Alpha Telephone Directory
               File size (bytes):       113419
               STIS Filename:           phnalpha.txt
               Also available:          phnalpha.dlm

   Title: NSF Organization Telephone Directory
               File size (bytes):       125281
               STIS Filename:           phnorg.txt

Document Type: Program Guideline

   Title: NSF 93-116 RESEARCH COLLECTIONS IN SYSTEMATICS AND ECOLOGY
               File size (bytes):       25692
               STIS Filename:           nsf93116.txt

   Title: NSF 94-66 Biotic Surveys and Inventories
               File size (bytes):       30678
               STIS Filename:           nsf9466.txt

Document Type: Recruit

   Title: VEP 96000 Assistant Director for Social, Behavioral, and
          Economic Sciences (SBE)
               File size (bytes):       5523
               STIS Filename:           vep96000.txt

Document Type: Report

   Title: NSF-car95 Fiscal Year 1995 Career Program Awards
               File size (bytes):       45946
               STIS Filename:           nsfcar95.txt
               Also available:          nsfcar95.xls nsfcar95.dlm

   Title: NSF-car95 Fiscal Year 1995 Career Program Awards
               File size (bytes):       45946
               STIS Filename:           nsfcar95.txt
               Also available:          nsfcar95.xls nsfcar95.dlm

Document Type: STIS

   Title: Document Types on STIS
               File size (bytes):       2532
               STIS Filename:           stistype.txt

   Title: Document Types on STIS
               File size (bytes):       2532
               STIS Filename:           stistype.txt

------------------------------------------------------------------------
                       ** FOR YOUR REFERENCE **
------------------------------------------------------------------------
HOW TO OBTAIN DOCUMENTS

The above files can be retrieved in electronic form using the STIS
system.  If you don't know how to use STIS, send an E-mail message to
stisinfo@nsf.gov (Internet).  You will receive
a copy of the STIS flyer via E-mail.

If you are already using STIS, you can use the information above to
retrieve these files:

Documents via E-mail:

     Send a message to stisserve@nsf.gov (Internet).
     Use the "STIS Filename" shown above in the "get" command.
     For example, to retrieve stistype.txt, the text of your message should be 
     as follows:
                       get stistype.txt

Anonymous FTP:

     FTP to stis.nsf.gov.  Use the "STIS Filename" shown above to
     retrieve a file.  For example, to retrieve stistype.txt, you would
     enter:
                       ftp> get stistype.txt

WAIS or Gopher:

     Do a word search on the filename as shown in the summary.

If you want a *printed* copy of a document:

     Send your name and postal mailing address, and the document title
     and number to "pubs@nsf.gov" (Internet).

If you have problems with the above procedures:

     Send a message to "stis@nsf.gov" (Internet).

From owner-sci-resources@net.bio.net Sat Feb 17 22:00:00 1996
Path: biosci!biosci!not-for-mail
From: BIOSCI Administrator <biosci-help@net.bio.net>
Newsgroups: bionet.sci-resources
Subject: NIH Guide, vol. 25, no. 03, pt. 1of2, 9 February 1996
Date: 18 Feb 1996 14:27:16 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 1499
Sender: daemon@net.bio.net
Approved: biosci-help@net.bio.net
Distribution: world
Message-ID: <4g8944$cak@net.bio.net>
NNTP-Posting-Host: net.bio.net

$$XID NIHGUIDE 19960209 V25N03 P1O2 ************************************
X-comment: RFAS described: ES-96-004, PA-96-022, PA-96-023, PA-96-024, PA-96-
X-URL: gopher://gopher.nih.gov:70/11/res/nih-guide/guide-files/96.02.09

NIH GUIDE - Vol. 25, No. 3 - February 9, 1996

$$INDEX BEGIN *******************************************************

                               NOTICES

$$INDEX N1 **********************************************************

RESEARCH SUPPLEMENTS TO PROMOTE THE RECRUITMENT OF INDIVIDUALS WITH
DISABILITIES INTO BIOMEDICAL RESEARCH CAREERS
National Institutes of Health
INDEX:  NATIONAL INSTITUTES OF HEALTH

$$INDEX N2 **********************************************************

RESEARCH SUPPLEMENTS FOR UNDERREPRESENTED MINORITIES
National Institutes of Health
INDEX:  NATIONAL INSTITUTES OF HEALTH

$$INDEX N3 **********************************************************

ANIMAL CARE AND USE:  HOT ZONES, GRAY ZONES, AND GO SLOW ZONES
National Institutes of Health
Public Responsibility in Medicine and Research
Tufts University School of Veterinary Medicine
INDEX:  NATIONAL INSTITUTES OF HEALTH; PUBLIC RESPONSIBILITY IN
MEDICINE & RESEARCH; TUFTS UNIVERSITY

$$INDEX N4 **********************************************************

NATIONAL HUMAN SUBJECT PROTECTIONS WORKSHOPS
National Institutes of Health
Food and Drug Administration
INDEX:  NATIONAL INSTITUTES OF HEALTH; FOOD AND DRUG ADMINISTRATION

               NOTICES OF AVAILABILITY (RFPs/RFAs/PAs)

$$INDEX R1 **********************************************************

ELECTRODES FOR FUNCTIONAL ELECTRICAL STIMULATION (RFP
NIH-NINDS-96-03)
National Institute of Neurological Disorders and Stroke
INDEX:  NEUROLOGICAL DISORDERS, STROKE

$$INDEX R2 **********************************************************

INSULATING BIOMATERIALS (RFP NIH-NINDS-96-04)
National Institute of Neurological Disorders and Stroke
INDEX:  NEUROLOGICAL DISORDERS, STROKE

$$INDEX R3 **********************************************************

CHANGES IN CLEARANCE OF ANTIEPILEPTIC DRUGS DURING PUBERTY (RFP
NIH-NINDS-96-05)
National Institute of Neurological Disorders and Stroke
INDEX:  NEUROLOGICAL DISORDERS, STROKE

$$INDEX R4 05/08/96 *************************************************

LINKING OF ENVIRONMENTAL AGENTS AND DISEASE (RFA ES-96-004)
National Institute of Environmental Health Sciences
INDEX:  ENVIRONMENTAL HEALTH SCIENCES

$$INDEX P1 **********************************************************

HUMAN MODELS AND MARKERS OF SKELETAL AGING (PA-96-022)
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Dental Research
National Institute of Diabetes and Digestive and Kidney Diseases
INDEX:  AGING; ARTHRITIS, MUSCULOSKELETAL; SKIN DISEASES; DENTAL
RESEARCH; DIABETES, DIGESTIVE, KIDNEY DISEASES

$$INDEX P2 **********************************************************

PILOT PROJECT RESEARCH GRANT PROGRAM FOR THE NIA (PA-96-023)
National Institute on Aging
INDEX:  AGING

$$INDEX P3 **********************************************************

NIDCD PROGRAM FOR POSTDOCTORAL RESEARCH TRAINING IN CLINICAL TRIALS
(PA-96-024)
National Institute on Deafness and Other Communication Disorders
INDEX:  DEAFNESS, OTHER COMMUNICATIONS DISORDERS

$$INDEX P4 **********************************************************

NICHD SMALL GRANTS PROGRAM (PA-96-025)
National Institute of Child Health and Human Development
INDEX:  CHILD HEALTH, HUMAN DEVELOPMENT

                               ERRATA

$$INDEX E1 **********************************************************

NOVEL PHARMACOTHERAPIES FOR COCAINE AND OTHER PSYCHOSTIMULANT
DEPENDENCE (RFA DA-96-003)
National Institute on Drug Abuse
INDEX:  DRUG ABUSE

THE NIH GUIDE IS AVAILABLE ELECTRONICALLY VIA BITNET OR INTERNET, BY
SUBSCRIPTION, AND IS ALSO ON THE NIH GOPHER (GOPHER.NIH.GOV).
ALTERNATIVE ACCESS IS THROUGH THE NIH GRANT LINE VIA MODEM (DATA LINE
301/402-2221); CONTACT DR. JOHN JAMES AT 301/435-2801 FOR DETAILS.

THE PHS STRONGLY ENCOURAGES ALL GRANT AND CONTRACT RECIPIENTS TO
PROVIDE A SMOKE-FREE WORKPLACE AND PROMOTE THE NON-USE OF ALL TOBACCO
PRODUCTS.  IN ADDITION, PUBLIC LAW 103-227, THE PRO-CHILDREN ACT OF
1994, PROHIBITS SMOKING IN CERTAIN FACILITIES (OR IN SOME CASES, ANY
PORTION OF A FACILITY) IN WHICH REGULAR OR ROUTINE EDUCATION,
LIBRARY, DAY CARE, HEALTH CARE OR EARLY CHILDHOOD DEVELOPMENT
SERVICES ARE PROVIDED TO CHILDREN.  THIS IS CONSISTENT WITH THE PHS
MISSION TO PROTECT AND ADVANCE THE PHYSICAL AND MENTAL HEALTH OF THE
AMERICAN PEOPLE.

ALL COMPETING GRANT APPLICATIONS SUBMITTED TO THE NATIONAL INSTITUTES
OF HEALTH MUST BE SENT TO:

DIVISION OF RESEARCH GRANTS
NATIONAL INSTITUTES OF HEALTH
6701 ROCKLEDGE DRIVE, ROOM 1040 - MSC 7710
BETHESDA, MD  20892-7710
BETHESDA, MD  20817 (for express/courier service)

THE GRANTS INFORMATION OFFICE, DRG, HAS BEEN INCORPORATED INTO THE
NEW OFFICE OF EXTRAMURAL OUTREACH & INFORMATION RESOURCES, OFFICE OF
EXTRAMURAL RESEARCH, OFFICE OF THE DIRECTOR, NIH.  REQUESTS FOR
APPLICATION FORMS, PUBLICATIONS, AND OTHER INFORMATION MAY BE
DIRECTED TO THE FOLLOWING:

OFFICE OF EXTRAMURAL OUTREACH & INFORMATION RESOURCES
6701 ROCKLEDGE DRIVE, MSC 7910
BETHESDA, MD  20892-7910
TELEPHONE:  (301) 435-0714
EMAIL:  GIRG@DRGPO.DRG.NIH.GOV

$$INDEX END *********************************************************

                               NOTICES

$$N1 BEGIN NOT-96-002 ***********************************************

RESEARCH SUPPLEMENTS TO PROMOTE THE RECRUITMENT OF INDIVIDUALS WITH
DISABILITIES INTO BIOMEDICAL RESEARCH CAREERS

NIH GUIDE, Volume 25, Number 3, February 9, 1996

P.T. 34, DD; K.W. 0710030, 0720005

National Institutes of Health

BACKGROUND

A recent report, titled "Changing America:  The New Face of Science
and Engineering" and issued by the President's Task Force on Women,
Minorities, and the Handicapped in Science and Technology, December
1989, has documented a very low participation rate for Americans with
disabilities in the science and engineering workforce.  To address
this problem for the biomedical and behavioral research workforce,
the National Institutes of Health (NIH)  and its awarding components
have developed an initiative that is designed to extend opportunities
to individuals with qualifying disabilities who are capable of
entering or resuming research careers.  Under this initiative,
individuals with disabilities are encouraged to pursue biomedical
research careers in areas within the missions of all the awarding
components of the NIH  through supplemental awards to certain ongoing
research grants.  It is hoped that the plan to provide funding at
several different stages in a research career will substantially
increase the number of individuals with disabilities in biomedical
research. The NIH  hereby notifies Principal Investigators holding
certain NIH  research grants of the availability of funds for
administrative supplements to existing grants for the support and
recruitment of scientists and students with disabilities.
Supplemental awards are available to support individuals with
disabilities from each of the following population groups:

o  HIGH SCHOOL STUDENTS.  Supplements under this program are designed
to foster an interest in biomedical and behavioral research.

o  UNDERGRADUATE STUDENTS.  This program  provides support for
undergraduate students to encourage them to continue on to graduate
level training in the biomedical and behavioral sciences.

o  GRADUATE RESEARCH ASSISTANTS.  Graduate students can receive
support under this program to develop their research capabilities.

o  INDIVIDUALS IN POSTDOCTORAL TRAINING.  This program provides
support during postdoctoral training to enable the development of an
independent career in biomedical research.

o  INVESTIGATORS DEVELOPING INDEPENDENT RESEARCH CAREERS. Staff and
faculty members with a doctoral  degree can receive short-and
long-term support for participation in an ongoing research project
while further developing their own independent research potential.

o  ESTABLISHED INVESTIGATORS WHO BECOME DISABLED.  This program will
provide additional support for established NIH  investigators and
project leaders on components of program projects and center grants
who become disabled.  The additional support may be requested for
assistants or special equipment that will facilitate a continuing
contribution to the goals of the parent grant. Because this program
differs in substantial ways from the other supplemental awards listed
here, it is described in a separate section below.

GENERAL PROVISIONS

For all of the supplemental programs listed above, the proposed
research experience must be an integral part of the approved, ongoing
research of the parent grant.  Also, with the exception of the
supplemental program for Established Investigators Who Become
Disabled, which is described in a separate section, individuals with
disabilities must be given the opportunity to interact with
individuals on the parent grant, to contribute intellectually to the
research, and to enhance his/her research skills and knowledge
regarding the particular area of biomedical science.  Furthermore,
the Principal Investigator must demonstrate a willingness and
understanding that the purpose of the award is to enhance the
research capability of the student or faculty member with a
disability, and that the research experience is intended to provide
opportunities for individuals with disabilities to develop into
independent, competitive research investigators.  All awards made
under these programs will be consistent with the goals of
strengthening the existing research program and the overall
programmatic balance and priorities of the funding component at the
NIH .  Awards will be made according to the policies and provisions
stated in this announcement. Applicants are encouraged to contact the
NIH institute staff identified in the INQUIRIES section below prior
to submission in order to obtain specific information about
application characteristics and requirements.  It is also recognized
that individual circumstances vary and, for unusual situations, NIH
program administrators should be consulted for a determination of
eligibility.

REASONABLE ACCOMMODATIONS

As a part of these awards, funds may be requested to make changes or
adjustments in the research setting that will make it possible for an
otherwise qualified employee with disabilities to perform the
essential functions associated with his/her role on the project.  The
accommodations requested under this program must be DIRECTLY related
to the performance of the proposed role on the research project and
must be appropriate to the disabilities of the individual.  Some
types of accommodations that might be provided under these awards
include:  specialized equipment, assistive devices, and personnel
such as readers, interpreters, or assistants.  In all cases, the
total funds for accommodations requested from the supplement must be
reasonable in relationship to the direct costs of the parent grant
and the nature of the supplemental award.

ELIGIBILITY

RESEARCH GRANTS ELIGIBLE FOR SUPPLEMENTAL AWARDS:  Principal
Investigators at domestic institutions who hold an active R01, R10,
R18, R22, R24, R35, R37, P01, P20, P30, P40, P41, P50, P51, P60, U01,
or U10 grant are eligible to submit a request for an administrative
supplement to the awarding component of the parent grant for any of
the supplemental programs offered here.  Principal Investigators
holding an active First Independent Research Support and Transition
(FIRST) Award (R29),  an Academic Research Enhancement Award (R15) or
a Small Grant Award (R03) also may apply for a supplement under this
program.  An R29  awardee may apply only when the minority candidate
is a high school, undergraduate, or graduate student.  An R15 awardee
or an R03 awardee may apply only when the minority candidate is a
high school or an undergraduate student.  However, exceptions to
these rules may be made.  Applicants should check with their awarding
component.  Minority supplements to R29,  R15 and R03 awards may
provide support above the established dollar limits.  The P20 and P30
award mechanisms are eligible for  supplements only when  they
contain research components.

In all cases, the parent grant must have support remaining for a
reasonable period at the time of a supplemental award.  Principal
Investigators are encouraged to submit an application no later than
three months before the anniversary date of the last two years
remaining on the parent grant.

Usually, each parent grant may have only one supplement for a person
with disabilities.  Appointment of more than one individual to a
single grant  depends on the nature of the parent grant, the
circumstances of the request, and the program balance of the awarding
component. Supplemental awards under these programs do not preclude a
separate supplement to support an underrepresented minority.

CANDIDATES ELIGIBLE FOR SUPPORT BY A SUPPLEMENTAL AWARD:  The purpose
of the request will be to support a high school student, an
undergraduate student, a graduate research assistant, an individual
in postdoctoral training, or a staff or faculty member with
disabilities to participate in ongoing research projects.  Awards
will be limited to citizens, non-citizen nationals of the United
States, and individuals who have been lawfully admitted for permanent
residence (i.e., in possession of an Alien Registration Receipt Card)
at the time of application.  Other specific eligibility requirements
relative to each type of award are set forth in the individual
program descriptions below. Individuals with disabilities may receive
support under these programs on only one grant at any time, but may
be supported by more than one grant during the development of their
research careers. Support under the supplement programs is not
transferable to another individual. The research supplement programs
for individuals with disabilities have been designed to attract
disabled individuals into research careers and are not intended to
provide an alternative means of supporting disabled individuals who
already receive support  from a research grant or a research training
grant or any other PHS funding  mechanism.  Disabled graduate
students or disabled individuals in postdoctoral training who are
supported by a National Research Service Award (NRSA) research
training grant may not be transferred to supplemental support prior
to the completion of their appointed period of training.  individuals
may not be transferred to supplemental support simply to increase the
availability of funds  to the parent grant for any other uses.

APPLICATION PROCEDURES

A request for a supplement may be submitted at any time.  IN MAKING
REQUESTS, THE GRANTEE INSTITUTION, ON BEHALF OF THE PRINCIPAL
INVESTIGATOR OF THE PARENT GRANT AND IN COOPERATION WITH THE
INDIVIDUAL WITH DISABILITIES, MUST SUBMIT THE REQUEST FOR
SUPPLEMENTAL FUNDS DIRECTLY TO THE AWARDING COMPONENT THAT SUPPORTS
THE PARENT GRANT.  The request is not to be submitted to the NIH
Division of Research Grants. Principal Investigators are encouraged
to obtain the address for submission from the NIH program
administrator on the parent grant.

The request for a supplemental award must include the following:

1.  A completed face page (with appropriate signatures) from Grant
Application Form PHS 398.  Include the title and grant number of the
parent grant in Item 1.

2.  A brief three to four page description, prepared by the Principal
Investigator of the parent grant, that includes:

a. A summary or abstract of the funded grant or project.

b. A description of the research experience proposed for the disabled
individual.

c. A description of how the research experience will expand and
foster the training or independent research capabilities of the
candidate and how the research experience will relate to the specific
research goals and objectives of the parent grant.

3.  A signed statement from the candidate with disabilities outlining
his/her research objectives and career goals.

4.  A biographical sketch of the candidate that includes evidence of
scientific achievement or interest.

5.  Social security number.  The PHS requests the Social Security
Number for the purpose of accurate identification, referral, and
review of applications and for efficient management of PHS grant
programs.

6.  A signed statement from the principal investigator  establishing
the eligibility of the individual with disabilities for support under
this program, including information on citizenship, and a description
of any previous PHS research grant support the  candidate has
received. This must include information certifying the individual's
citizenship, the nature of the disability, any occupational
limitations associated with the disability, and the types of
accommodations that will permit the individual to undertake the
proposed research experience.  Also, the institution must indicate
its contribution to aid accommodation of the candidate to the
research environment.

7.  A proposed budget entered on budget pages from Grant Application
Form PHS 398,  related to the percent effort (where appropriate) for
the research experience in the first and future years.  All special
accommodations requested must be detailed and justified in the budget
section.  If the initial budget period requested is less than 12
months, the budget should be prorated accordingly.

8.  Documentation, if applicable, that the proposed research
experience was approved by the Institutional Animal Care and Use
Committee (IACUC) or human subjects Institutional Review Board (IRB)
of the grantee institution must be provided.  Adherence to the NIH
policy for including women and minorities in clinical studies must
also be insured if additional human subjects~ involvement is planned
for the supplement component.

9.  A copy of the most recent  official transcript if the candidate
is a high school, undergraduate or graduate student.

10.  If the individual with disabilities is a student at another
institution, the application also must include an appropriately
signed letter from a responsible official at the institution of
matriculation indicating that participation at the stated level of
effort is approved and will not detract from or interfere with
his/her course of studies.

11.  If any of the research is to be conducted at a site other than
the grantee institution, an appropriately signed letter from the
institution where the research is to be conducted must be submitted.
The request must be signed by the individual with disabilities, the
Principal Investigator, and the appropriate institutional business
official.

REVIEW CRITERIA

The staff of the particular awarding component will review requests
for supplements using the following general criteria:

1.  The qualifications of the individual with disabilities including
career goals, prior research  training, research potential and any
relevant experience.

2.  The plan for the proposed research experience in the supplemental
request and its relationship to the parent grant.

3.  The appropriateness of the proposed accommodations for the
candidate and his/her role on the research project.  The
appropriateness of the costs of the proposed accommodations to be
paid from the supplement relative to the cost of the parent project
and the nature of the requested supplemental award.  Evidence that
the proposed accommodations, including those provided by the grantee
institution, will be sufficient to enable the candidate to adapt to
the research environment.

4.  Evidence from the Principal Investigator that the experience will
enhance the research potential, knowledge, and/or skills of the
candidate.

5.  Evidence from the Principal Investigator that the activities of
the individual with disabilities will be an integral part of the
project.

6.  Evidence of educational achievement and interest in science if
the candidate is a student. Additional criteria related to the
specific programs may also apply and are described below.

FUNDING

The decision to fund a supplement will take approximately  eight
weeks from receipt of a completed application.  Applicants for
summer-only research appointments must submit early enough to ensure
that funding and accommodations are in place by the time the summer
experience is scheduled to begin.  In most cases, during the first
budget period, funds will be provided as an administrative supplement
to the parent grant.  In subsequent years, continued funding for the
supplement is contingent on funding of the parent grant and cannot
extend beyond the current competitive segment of the parent grant and
availability of funds.

Continuation of support for the individual with disabilities in the
remaining years of the competitive segment of the grant will depend
upon a satisfactory review by the awarding component of progress on
both the parent grant and the supplemental project, the research
proposed for the next budget period, and the appropriateness of the
proposed budget for the proposed effort.

In non-competing applications, the progress report and budget for the
individual with disabilities must be clearly delineated from the
progress report for the parent grant.  The progress report in both
non-competing and competing applications must include information
about the research activities supported by the supplement even if
support for future years is not requested.

In future competing applications, funds for continuation of support
of the individual with disabilities will depend on the successful
renewal of the parent grant and will be handled as follows:

For students who have not yet completed their research experience,
funds for the continuation of support must be requested as a research
supplement to ensure continued tracking of the individual supported.
The request for continued support should not be included in the
competing renewal, but instead, should be prepared as a letter with
information on research progress and accomplishments of the
candidate.  The request must be addressed to the program
administrator of the parent grant and must be submitted promptly in
anticipation of a renewal award to avoid an interruption of support.
Support to individual students by this mechanism will be limited to
five years.  Additional time may be considered, but must be well
justified.

Funds for the continuation of support for a postdoctoral fellow or an
investigator with disabilities must be requested by name in the
parent grant application at the time of renewal and may not be
requested as a research supplement. Postdoctoral fellows and
investigators are expected to be fully  integrated in the research
laboratory when considered for continuation of support.

A Statement of Appointment form (PHS 2271, rev. 1/95), which will be
provided by the NIH awarding component, must be completed and sent to
the awarding component whenever an individual is appointed to a
research supplement. In addition, the Statement of Appointment Form
must be completed and submitted each time an individual is
reappointed in a new budget period and whenever the name or permanent
mailing address of the appointed individual changes.  The form must
be signed by both the appointed individual and the Principal
Investigator of the supplemental research grant.

DESCRIPTION OF THE INDIVIDUAL RESEARCH SUPPLEMENT PROGRAMS

1.  HIGH SCHOOL STUDENTS

The purpose of this program is to provide  high school students with
disabilities, who have demonstrated an interest and an aptitude for
scientific pursuits, with a meaningful experience in various aspects
of health-related research to stimulate interest in a career in
science.

ELIGIBILITY

Any qualified high school student with disabilities who is enrolled
in good standing at a local high school and is interested in
biomedical or behavioral research is encouraged to participate in
this program.

PROVISIONS

This supplement is not to exceed $2,000 in direct cost, including
supplies during a summer research experience. A part-time experience
during the regular school year would be reimbursed at the same hourly
rate.  Funds over and above this $2,000 limit may be requested to
permit accommodation to the research environment.  This may include
research equipment if it is directly related to both the project and
to accommodating the disabilities of the student.  In all cases,
equipment may only be purchased with prior approval of the NIH
awarding component.

Students are expected to devote sufficient effort to the research
project and related activities during the period of support to gain
insight into the process of scientific discovery.  Support may be for
a minimum of three months during any one year which may include a
mixture of full-time summer experience and part-time experience
during the school year.  Principal Investigators are encouraged to
seek high school students who will devote at least two years to this
program (i.e., equivalent to two three-month, full-time,
periods).Exceptions to the latter will be considered, depending on
the circumstances of the applicant, the parent grant, and the
specific request.

See the GENERAL PROVISIONS section (above) for information about
application procedures, review criteria, and funding.

2.  UNDERGRADUATE STUDENTS

DESCRIPTION

This supplemental program provides an opportunity for any qualified
undergraduate student with disabilities, who is interested in
biomedical or behavioral research, to participate in a research
project at a research institution during the summer months or during
the school year.  This experience will be separate and apart from any
requirement of the regular academic program.  The success of this
program is dependent on the ability of the Principal Investigator to
identify appropriate students.  A number of procedures may be used to
match investigators to appropriate college students:  (1) the
Principal Investigator may identify a student and initiate the
request for the supplement; (2) the institution may make the pairing
of the student with the Principal Investigator; (3) the student may
contact a grantee institution or an investigator and request a
research experience.

ELIGIBILITY

The student may be affiliated with either the applicant institution
or any other academic institution.  Any qualified undergraduate
student with disabilities who is interested in biomedical or
behavioral research is encouraged to participate in this program.

PROVISIONS

This supplement generally should not exceed $6.00 per hour for salary
plus $125 per month for supplies and travel.  Funds over and above
this limit may be requested to permit accommodation to the research
environment.  This may include research equipment, but only if it is
directly related to both the project AND to accommodating the
disabilities of the student.  In all cases, equipment may only be
purchased with prior approval of the NIH awarding component.

Students are expected to devote an equivalent of at least three
months full-time effort to the research project and related
activities in any one year, and in most cases the period of support
for any individual should last at least two years.  Exceptions to the
latter will be considered, depending on the circumstances of the
applicant, the parent grant, and the specific request. See the
GENERAL PROVISIONS section (above) for information about application
procedures, review criteria, and funding.

3.  GRADUATE RESEARCH ASSISTANTS

DESCRIPTION

The objective of this program is to offer additional encouragement to
graduate students with disabilities who have the potential to become
researchers in biomedical or behavioral sciences and give them an
opportunity to develop their research capability further.

ELIGIBILITY

Any graduate student with disabilities who is enrolled in a masters
or a doctoral degree program in biomedical or behavioral sciences is
eligible for consideration.

PROVISIONS

The NIH will provide salary support in addition to other necessary
expenses, such as supplies and travel, to enable the individual to
participate as a graduate research assistant in funded research
projects.  As in the past, the NIH will continue to consider the
compensation for the personal services of graduate students and other
employees rendered to an NIH research project to be allowable as long
as the compensation is reasonable and (1) conforms to the
established, consistently applied salary and wage policies of the
institutions and (2) reflects the percentage of time actually devoted
to the PHS-funded project.  For graduate students this compensation
may include tuition remission paid as, or in lieu of, wages provided
that, the student is in a bona fide employer-employee relationship
with the institution for the work performed, and payment is
conditioned explicitly on the performance of necessary work.
Reasonable compensation for graduate students must not exceed the
amount allowable for a first year postdoctoral level staff member, at
the same institution, performing comparable work.  Additional funds
up to $3000 per year may be requested for supplies and travel.  Funds
may not be used to purchase equipment.  Funds may also be requested
to permit accommodation to the research environment.  This may
include research equipment, but only if it is directly related to
both the project AND to accommodating the disabilities of the
student.  In all cases, equipment may only be purchased with prior
approval of the NIH awarding component.

See the GENERAL PROVISIONS section (above) for information about
application procedures, review criteria, and funding.

4.  INDIVIDUALS IN POSTDOCTORAL TRAINING

DESCRIPTION

These supplements provide support to individuals with disabilities in
the postdoctoral phase of training to participate in ongoing research
projects that will assist in the development of a career in
biomedical or behavioral research.  Toward the end of the supplement
award, candidates should be encouraged to apply for fellowships,
FIRST awards, and sources of independent support.

ELIGIBILITY

The individual in postdoctoral training may be affiliated with either
the applicant institution or any other institution.  Only under
extraordinary circumstances, that must be well justified in the
application, would it be acceptable for the candidate to continue
working with his/her former predoctoral mentor.

PROVISIONS

Support will be provided for a salary in addition to other necessary
expenses, such as supplies and travel, to enable the individual to
participate as a postdoctoral research assistant in funded research
projects.  The requested salary must be in accordance with the salary
structure of the grantee institution and consistent with the level of
effort. Additional funds up to $6,000 may be requested for supplies
and travel.  Funds may also be requested to permit accommodation to
the research environment.  This may include research equipment, but
only if it is directly related to both the project AND to
accommodating the disabilities of the individual.  In all cases,
equipment may only be purchased with prior approval of the NIH
awarding component.

See the GENERAL PROVISIONS section (above) for information about
application procedures, review criteria, and funding.

5.  INVESTIGATORS DEVELOPING INDEPENDENT RESEARCH CAREERS

DESCRIPTION

These supplements provide either short- or long-term research support
for staff or faculty members with disabilities to enhance their
research skills leading to an independent research career.

o  Short-term Investigator Research Supplement.  This supplement
provides short-term support for staff or faculty members to conduct
full-time research for three to five months each year, during the
summer or another portion of the academic year, over a maximum period
of four years.

o  Long-term Investigator Research Supplement.  This supplement
provides long-term research support for staff or faculty members to
conduct research in the biomedical or behavioral sciences.  Support
is provided for up to four years at a minimum of 30 percent effort
during each 12-month period.

ELIGIBILITY

The investigator with disabilities may be affiliated with either the
applicant institution or any other institution.  The investigator
must have a doctoral degree, be beyond the level of a research
trainee, be a member of the staff or faculty, and have at least one
year of postdoctoral experience.  The investigator may have received
prior research or research training support from the NIH  or support
under the Minority Biomedical Research Support (MBRS), Minority-
Research Infrastructure Support Program (M-RISP), Minority Access to
Research Careers (MARC), Career Opportunities in Research Education
and Training (COR), small grants, or Academic Research Enhancement
Awards (AREA) programs.  But, an individual who has received
independent research support as a Principal Investigator on an
individual research grant (e.g., R01, R29) or as a project leader on
a program project or center grant (e.g., P01, P50), or as a Principal
Investigator on an individual research career award (e.g., K01, K02,
K08) is not eligible for support under this program.

PROVISIONS

The faculty or staff supplemental award is for a maximum of $50,000
in direct costs per year.  A maximum of $40,000 may be requested for
salary and fringe benefits.  Funds up to $10,000 may also be
requested for research supplies and travel.  Funds over and above
this $50,000 limit may be requested to permit accommodation to the
research environment.  This may include research equipment, but only
if it is directly related to both the project AND to accommodating
the disabilities of the investigator.  In all cases, equipment may
only be purchased with prior approval of the NIH  awarding component.
The maximum period of support for any investigator is four years.

The amount of salary requested must be consistent with the policies
of the parent grantee institution (and, if applicable, the disabled
investigator's employing institution) and must be related to the
percent effort of the investigator.

See the GENERAL PROVISIONS section (above) for application
procedures, review criteria, and funding.

6.  SUPPLEMENTS FOR ESTABLISHED INVESTIGATORS WHO BECOME DISABLED

DESCRIPTION

Established investigators on NIH research, program project, or center
grants, who become disabled during the current project period, may
request special accommodations to permit completion of the currently
funded research project.

ELIGIBILITY

Any currently funded Principal Investigator or Co-Investigator or
other senior staff (hereinafter referred to as Established
Investigator) on an NIH  research project grant, program project
grant, or center grant may request support for special equipment, an
assistant, or other modifications to facilitate accommodation to a
disabling injury or illness that has occurred during the current
project period.

PROVISIONS

Support will be limited to items that will permit the investigator to
complete the remaining years of a currently funded research project.
This might include:  salary support for an individual who can assist
the Established Investigator in meeting the goals of the research
project, specialized equipment, or modifications of the working
environment.  In all cases, the requested support must be consistent
with the type of disability and the nature of the approved research.
The total amount of support requested under this supplement must be
reasonable in relationship to the direct costs of the parent award
and the Established Investigator's role and effort on the project.
In future competing applications, funds for continuation of the
accommodations provided under this supplement must be requested in
the parent grant application and may NOT be requested as a research
supplement.

APPLICATION PROCEDURES

A request for a supplement may be submitted at any time.  In making
requests, the grantee institution, on behalf of the Established
Investigator, must submit the request for supplemental funds directly
to the awarding component that supports the parent grant.  The
request must include the following:

o  A completed face page from Grant Application Form PHS 398 with the
title and grant number of the parent grant and a statement that
specifies which type of supplement is being requested.

o  A statement by the Established Investigator describing the nature
of the disability and the attendant limitations on his/her capacity
to complete the goals established for the current project period.

o  A statement from the institution certifying the disability and
describing the types of accommodations requested and their
relationship to the research project and the disabilities of the
Established Investigator.

o  A proposed budget entered on budget pages from Grant Application
Form PHS 398.  The budget must reflect all special accommodations to
support the adaptation of the Established Investigator to the
research environment. The request must be signed by the Principal
Investigator, the Established Investigator with disabilities (if
other than the Principal Investigator), and the appropriate
institutional business official.

REVIEW CRITERIA

The staff of the particular awarding component will review requests
for supplements using the following criteria:

o  The appropriateness of the proposed accommodations for the
Established Investigator regarding his/her role on the research
project and the nature of the disability.

o  The appropriateness of the cost of the proposed accommodations to
be paid from the supplement in relationship to the total direct cost
of the parent project.

FUNDING

See the section on funding in the GENERAL PROVISIONS section, above.

INQUIRIES

Principal Investigators interested in participating in any of these
supplemental programs are encouraged to contact NIH  staff
administering the parent grant.  For general information about the
Supplements for Individuals with Disabilities, contact the following
staff person in the appropriate awarding component:

NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM
Director, Alcohol Research Centers Program
Willco Building, Room 402
Bethesda, MD  20892-7003
Telephone:  (301) 443-1273
FAX:  (301) 594-0673
Email:  tvanderv@willco.niaaa.nih.gov

NATIONAL INSTITUTE ON AGING
Deputy Associate Director, Office of Extramural Affairs
Gateway Building, Suite 2C218
Bethesda, MD  20892-9205
Telephone:  (301) 496-9322
FAX:  (301) 402-2945
Email:  rb42h@nih.gov

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Director, Office of Science Training and Manpower Development
Solar Building, Room 3C21
Bethesda, MD  20892
Telephone:  (301) 496-7291
FAX:  (301) 402-0369
Email:  mh35c@nih.gov

NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
Director, Centers Program
Natcher Building, Room 5AS-19F
Bethesda, MD  20892
Telephone:  (301) 594-5052
FAX:  (301) 480-4543
Email:  freemanj@ep.niams.nih.gov

NATIONAL CANCER INSTITUTE
Deputy Director, Division of Extramural Activities
Executive Plaza North, Suite 600
Bethesda, MD  20892
Telephone:  (301) 496-4218
FAX:  (301) 402-0956
Email:  grayp@dea.nci.nih.gov

NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT
Special Assistant to the Deputy Director
Building 31, Room 2A03, MSC 2425
Bethesda, MD  20892-2425
Telephone:  (301) 496-0104
FAX:  (301) 402-1104
Email:  topperh@hd03.nichd.nih.gov

NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS
Deputy Director, Division of Human Communication
6120 Executive Boulevard, Room 400C, MSC 7180
Bethesda, MD  20892-7180
Telephone:  (301) 496-5061
FAX:  (301) 402-6251
Email:  Judith_Cooper@nih.gov

NATIONAL INSTITUTE OF DENTAL RESEARCH
Assistant Director for Program Development
Natcher Building, Room 4AN-24B, MSC 6402
Bethesda, MD  20892-6402
Telephone:  (301) 594-2089
FAX:  (301) 480-8318
Email:  bravemann@de45.nidr.nih.gov

NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
Assistant Director for Grants
45 Center Drive, Room 6AS-49E, MSC 6600
Bethesda, MD  20892-6600
Telephone:  (301) 594-8842
FAX:  (301) 480-3504
Email:  garthunej@ep.niddk.nih.gov

NATIONAL INSTITUTE ON DRUG ABUSE
Chief, Special Populations Office
5600 Fishers Lane, Room 10A-10
Rockville, MD  20857
Telephone:  (301) 443-0441
FAX:  (301) 443-9127
Email:  Lula_Beatty@nih.gov

NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES
Director, Division of Extramural Research and Training
Building 3, Room 301A
P.O. Box 12233
Research Triangle Park, NC  27709
Telephone:  (919) 541-7723
FAX:  (919) 541-2843
Email:  sassaman@niehs.nih.gov

NATIONAL EYE INSTITUTE
Research Resources Officer
6120 Executive Boulevard, Suite 350, MSC 7164
Rockville, MD  20892-7164
Telephone:  (301) 496-5301
FAX:  (301) 402-0528
Email:  rjh@eps.nei.nih.gov

NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
Assistant Director, Referral and Liaison
45 Center Drive, Room 2AN-18F, MSC 6200
Bethesda, MD  20892-6200
Telephone:  (301) 594-3833
FAX:  (301) 402-0156
Email:  renea@gm1.nigms.nih.gov

NATIONAL HEART, LUNG AND BLOOD INSTITUTE
Director, Division of Extramural Affairs
6701 Rockledge Drive, Suite 7100, MSC 7924
Bethesda, MD  20892
Telephone:  (301) 435-0260
FAX:  (301) 480-3460
Email:  rg33k@nih.gov

NATIONAL CENTER FOR HUMAN GENOME RESEARCH
Chief, Mapping Technology Branch
Building 38A, Room 610
Bethesda, MD  20892
Telephone:  (301) 496-7531
FAX:  (301) 480-2770
Email:  bettie_graham@nih.gov

NATIONAL LIBRARY OF MEDICINE
Acting Associate Director, Division of Extramural Programs
Building 38A, 5N505
Bethesda, MD  20892
Telephone:  (301) 496-4621
FAX:  (301) 402-0421
Email:  corn@1hc.nlm.nih.gov

NATIONAL INSTITUTE OF MENTAL HEALTH
Deputy Associate Director for Special Populations
5600 Fishers Lane, Room 17C-14
Rockville, MD  20857
Telephone:  (301) 443-2847
FAX:  (301) 443-8552
Email:  sragland@nih.gov

NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Deputy Director, Division of Extramural Activities
Federal Building, Room 1016
Bethesda, MD  20892
Telephone:  (301) 496-4188
FAX:  (301) 402-4370
Email:  ed25b@nih.gov

NATIONAL INSTITUTE OF NURSING RESEARCH
Director, Extramural Programs
45 Center Drive, Room 3AN-12, MSC 6300
Bethesda, MD  20892-6300
Telephone:  (301) 594-6906
Fax: (301) 480-8260
Email:  depdir@ep.ninr.nih.gov

NATIONAL CENTER FOR RESEARCH RESOURCES
Senior Advisor to the Director
Building 12A, Room 4007, MSC 5662
Bethesda, MD  20892-5662
Telephone:  (301) 496-5795
FAX:  (301) 402-0006
Email:  rogere@od12a.ncrr.nih.gov

AUTHORITY AND REGULATIONS

The statutory authorities for these grant awards are sections 301,
510, 515, and 504 of the Public Health Service Act.  Federal
regulations at 42 CFR Part 52, "Grants for Research Projects" and 45
CFR Part 74, "Administration of Grants," are applicable to these
awards.  Grants must be administered in accordance with the Public
Health Service Grants Policy Statement.

$$N1 END ************************************************************

$$N2 BEGIN NOT-96-003 ***********************************************

RESEARCH SUPPLEMENTS FOR UNDERREPRESENTED MINORITIES

NIH GUIDE, Volume 25, Number 3, February 9, 1996

P.T. 34, FF; K.W. 0710030, 0720005

National Institutes of Health

BACKGROUND

During 1987 and 1988, the Director of the National Institutes of
Health (NIH) and the Advisory Committee to the Director (ACD) held a
series of regional meetings throughout the United States.  At these
meetings, testimony was presented by concerned individuals and
organizations regarding the underrepresentation of minorities in
biomedical and behavioral research.  Although the NIH currently
provides opportunities for minorities through the traditional
research grant programs and through special initiatives supported by
various components of the NIH (see APPENDIX for listing), the
testimony indicated that efforts of the NIH should be increased.  In
addition, the NIH recognizes the need to increase the number of
underrepresented minority scientists participating in biomedical and
behavioral research.

In response to these concerns, the NIH is emphasizing the use of
administrative supplements to attract underrepresented minorities
into biomedical and behavioral research.  The mechanisms described in
this announcement have been endorsed by all the awarding components
of the NIH and are designed to provide support for research
experiences at grantee institutions for minorities throughout the
continuum from high school to the faculty level.

The NIH hereby notifies all Principal Investigators holding NIH
research grants that funds are available for administrative
supplements to existing grants for the support and recruitment of
underrepresented minority investigators and students.  The aim of
these supplements is to attract and encourage minority individuals to
enter and pursue biomedical and behavioral research careers in areas
within the missions of all the awarding components of the NIH by
providing supplemental funds to certain ongoing research grants (see
the Eligibility section under GENERAL PROVISIONS).

For the purpose of this announcement, underrepresented minority
students and investigators are defined as individuals belonging to a
particular ethnic or racial group that has been determined by the
grantee institution to be underrepresented in biomedical or
behavioral research.  Awards will be limited to citizens or non-
citizen nationals of the United States or to individuals who have
been lawfully admitted for permanent residence (i.e., in possession
of an Alien Registration Receipt Card) at the time of application.
In awarding supplements, the NIH will give priority to projects
involving African American (Black), Hispanic American, Native
American and Alaskan Natives, and Pacific Islander or other ethnic or
racial group members who have been found to be underrepresented in
biomedical or behavioral research nationally.  Before submitting an
application for a research supplement, applicants are encouraged to
call their program administrator at the NIH to discuss any aspects of
this program that need clarification.

The NIH anticipates, that by providing scientific opportunities such
as those listed below the number of minorities entering and remaining
in biomedical research careers will increase.

o  MINORITY HIGH SCHOOL STUDENTS: This program will support minority
high school students who have expressed an interest in biomedical or
behavioral sciences.

o  MINORITY UNDERGRADUATE STUDENTS: This program will support
minority undergraduate students who have demonstrated an interest in
biomedical or behavioral sciences and wish to pursue graduate level
training in these areas.

o  MINORITY GRADUATE RESEARCH ASSISTANTS: This program will provide
support to assist minority predoctoral students who wish to develop
research capabilities in the biomedical and behavioral sciences.

o  MINORITY INDIVIDUALS IN POSTDOCTORAL TRAINING: This program will
provide support for minority individuals who wish to participate as
postdoctoral researchers in ongoing research projects in preparation
for independent careers in biomedical or behavioral research.

o  MINORITY INVESTIGATORS: This program will provide short- and
long-term opportunities for minority staff and faculty who wish to
participate in ongoing research projects while further developing
their own independent research potential.

GENERAL PROVISIONS

In all cases, the proposed research experience must be an integral
part of the approved ongoing research of the parent grant.  As part
of this research experience, the minority individual must be given
the opportunity to interact with individuals on the parent grant, to
contribute intellectually to the research, and to enhance  her/his
research skills and knowledge regarding the particular area of
biomedical science.  Furthermore, the Principal Investigator must
demonstrate a willingness and understanding that the purpose of the
award is to enhance the research capability of the minority student
or faculty member and that the research experience is intended to
provide opportunities for minority individuals to develop as
independent, competitive research investigators.  Supplemental awards
will be consistent with the goal of strengthening the existing
research program and with the overall programmatic balance and
priorities of the funding component of the NIH.  Awards will be made
according to the policies and provisions stated in this announcement
or as further specified by the NIH component funding the parent
grant.

Applicants are encouraged to contact the NIH institute staff listed
under INQUIRIES prior to submission to obtain specific information
about preparing and submitting an application.  It is also recognized
that individual circumstances vary, and for unusual situations, NIH
program administrators should be consulted for a determination of
eligibility.

ELIGIBILITY

Principal Investigators at domestic institutions who hold an active
R01, R10, R18, R22, R24, R35, R37, P01, P20, P30, P40, P41, P50, P51,
P60, U01, U10, U41, or U42 grant are generally eligible to submit a
request for an administrative supplement to the awarding component of
the parent grant for any of the supplemental programs offered here.
Principal Investigators holding an active First Independent Research
Support and Transition (FIRST) Award (R29), an Academic Research
Enhancement Award (R15) or a Small Grant Award (R03) also may apply
for a supplement under this program.  An R29 awardee may apply only
when the minority candidate is a high school, undergraduate, or
graduate student.  An R15 awardee or an R03 awardee may apply only
when the minority candidate is a high school or an undergraduate
student.  However, exceptions to these rules may be made.  Applicants
should check with their awarding component.  Minority supplements to
R29, R15 and R03 awards may provide support above the established
dollar limits.  The P20, P30 and P60 award mechanisms are eligible
for  supplements only when they contain research components.

In all cases, the parent grant must have support remaining for a
reasonable period at the time of a supplemental award.  Principal
Investigators are encouraged to submit an application no later than
three months before the anniversary date of the last two years
remaining on the parent grant.  The purpose of the application is to
request support for an underrepresented minority high school student,
undergraduate student, graduate research assistant, individual in
postdoctoral training, or a staff or faculty member to participate in
an ongoing research project.  Specific eligibility requirements
relative to each type of award are set forth in the description of
the individual supplement programs (below).

Usually, each parent grant may support only one minority supplement.
Appointment of more than one individual to a single grant  depends on
the nature of the parent grant, the circumstances of the request, and
the program balance of the NIH awarding component.  Minority
individuals may receive support from only one of these supplement
programs at a time, but may be supported by more than one minority
supplement during the development of their research careers.  Support
under the supplement programs is not transferable to another
individual or transportable to another institution.

The minority supplement programs have been designed to attract
underrepresented minority individuals into research careers and are
not intended to provide an alternative means of supporting minority
individuals who already receive support from a research grant or a
research training grant or any other PHS funding mechanism.  Minority
graduate students or individuals in postdoctoral training who are
supported by a National Research Service Award (NRSA) Institutional
research training grant may not be transferred to supplemental
support prior to the completion of their appointed period of
training. Individuals may not be transferred to a minority supplement
to increase the availability of funds  to the parent grant for any
other uses.

APPLICATION PROCEDURES

A request for a supplement may be submitted at any time. In making
requests, the grantee institution, on behalf of the Principal
Investigator of the parent grant and in cooperation with the minority
individual, must submit the request for supplemental funds directly
to the awarding component that supports the parent grant.  The
request  should not  be submitted to the NIH Division of Research
Grants.  Principal Investigators are encouraged to obtain the address
for submission from the NIH program administrator on the parent
grant.

The request for a supplemental award must include the following:

1.  A completed face page (with appropriate signatures) from grant
application form PHS 398.  Include the title and grant number of the
parent grant on line 1 and the type of supplement being requested on
line 2.

2.  A brief three to four page description, prepared by the Principal
Investigator of the parent grant, that includes:

a.  a summary or abstract of the funded grant or project.

b.  a description of the research experience proposed for the
minority individual.

c.  a description of how the research experience will expand and
foster the independent research  capabilities of the minority
individual, and how the proposed experience relates to the specific
research goals and objectives of the parent grant.

3.  A signed statement from the minority individual outlining
her/his research objectives and career goals.

4.  A biographical sketch of the minority individual that includes
evidence of scientific achievement or interest.

5.  Social security number of the minority individual. (The PHS uses
the Social Security Number for the purpose of accurate
identification, referral, and review of applications and for
efficient management of PHS grant programs.  Although provision of
the Social Security Number is voluntary, it will facilitate the
processing of your request.)

6  A signed statement from the Principal Investigator establishing
the eligibility of the minority individual for support under this
program including information on ethnicity, citizenship, and a
description of any previous PHS research grant support the minority
individual has received.

7.  A proposed budget entered on budget pages from grant application
form PHS 398, related to the percent effort (where appropriate) for
the research experience of the minority individual during the first
and future years.  If the initial budget period requested is less
than 12 months, the budget must be prorated accordingly.

8.  Documentation, if applicable, that the proposed research
experience was approved by the Institutional Animal Care and Use
Committee (IACUC) or human subjects Institutional Review Board (IRB)
of the grantee institution must be provided.  Adherence to the NIH
policy for including women and minorities in clinical studies must
also be insured if additional human subjects' involvement is planned
for the supplement component.

9.  A copy of the most recent official transcript, if the minority
candidate is a high school, undergraduate, or graduate student.

10.  If the minority individual is a student at another institution,
the application  must include an appropriately signed letter from a
responsible official at the institution of matriculation indicating
that participation at the stated level of effort is approved and will
not detract from or interfere with the students course of studies.

11.  If any of the research is to be conducted at a site other than
the grantee institution, an appropriately signed letter from the
institution where the research is to be conducted  must be submitted.

The request must be signed by the minority individual, the Principal
Investigator, and the appropriate institutional business official.

REVIEW CRITERIA

The staff of the particular awarding component will review requests
for supplements using the following general criteria:

1.  The qualifications of the minority individual including career
goals, prior research training, research potential and any relevant
experience.

2.  Evidence of educational achievement and interest in science, if
the minority candidate is a student.

3.  The plan for the proposed research experience in the supplemental
request and its relationship to the parent grant.

4.  Evidence from the Principal Investigator that the experience will
enhance the research potential, knowledge and/or skills of the
minority individual, and that adequate mentorship will be provided.

5.  Evidence from the Principal Investigator that the activities of
the minority individual are an integral part of the project.

FUNDING

The decision to fund a supplement  will take approximately eight
weeks from  receipt of a complete application.  Applicants for
summer-only research appointments must submit early enough to ensure
that funding is in place by the time the summer experience is
scheduled to begin.  In most cases, during the first budget period,
funds will be provided as an administrative supplement to the parent
grant.  In subsequent years, continued funding for the supplement is
contingent on continued funding of the parent grant and cannot extend
beyond the current competitive segment of the parent grant and the
availability of funds.

 Continuation of support for the minority individual in the remaining
years of the competitive segment of the grant will depend upon
satisfactory review by the NIH awarding component of progress for
both the parent grant and the supplemental project, the research
proposed for the next budget period, and the appropriateness of the
proposed budget  for the proposed effort.

In non-competing continuation applications, the progress report and
budget for the minority supplement must be clearly delineated from
the progress report and budget for the parent grant.  The progress
report must include information about the research activities
supported by the supplement, even if support for future years is not
requested.

In future competing applications, funds for continuation of support
of the minority individual will depend on the successful renewal of
the parent grant and will be handled as follows:

For minority students who have not yet completed their research
experience, funds for the continuation of support must be requested
as a research supplement to ensure continued tracking of the
individual supported.  The request for continued support should not
be included in the competing renewal, but instead, should be prepared
as a letter with information on research progress and accomplishments
of the minority individual.  The request must be addressed to the
program administrator of the parent grant and must be submitted
promptly in anticipation of a renewal award to avoid an interruption
of support.  Support to individual students by this mechanism will be
limited to five years.  Additional time may be considered, but must
be well justified.

Funds for the continuation of support for a minority postdoctoral
fellow or a minority investigator must be requested by name in the
parent grant application at the time of renewal and may not be
requested as a research supplement.  Minority postdoctoral fellows
and investigators are expected to be fully integrated in the research
laboratory when considered for continuation of support.

A Statement of Appointment form (PHS 2271, rev. 1/95), which will be
provided by the NIH awarding component, must be completed and sent to
the awarding component whenever an individual is appointed to a
Research Supplement for Underrepresented Minorities.  In addition,
the Statement of Appointment Form must be completed and submitted
each time an individual is reappointed in a new budget period and
whenever the name or permanent mailing address of the appointed
individual changes.

DESCRIPTIONS OF THE INDIVIDUAL RESEARCH SUPPLEMENT PROGRAMS

1.  RESEARCH SUPPLEMENTS FOR UNDERREPRESENTED MINORITY HIGH SCHOOL
STUDENTS

DESCRIPTION

The purpose of this program is to provide minority high school
students an opportunity to obtain a meaningful experience in various
aspects of health-related research to stimulate their interest in
careers in biomedical or behavioral science.

ELIGIBILITY

Any minority high school student who is currently enrolled and in
good standing at  her or his high school and is interested in
biomedical or behavioral research is encouraged to participate in
this program.

PROVISIONS

This supplement is not to exceed $2,000 per student in direct cost,
including supplies, for a summer experience.  A part-time experience
during the regular school year would be reimbursed at the same hourly
rate.  Equipment may not be purchased using these funds. Students are
expected to devote sufficient effort to the research project and
related activities during the period of support to gain insight into
the process of scientific discovery.  Support for at least three
months is encouraged during any one year, which may include a mixture
of full-time summer experience and part-time experience during the
school year.  Principal Investigators are encouraged to seek minority
high school students who will devote at least two years to this
program (i.e., equivalent to two three-month, full-time periods).
Exceptions to the latter will be considered, depending on the
circumstances of the applicant, the parent grant, and the specific
request.

See the GENERAL PROVISIONS section for information about application
procedures, review criteria, and funding.

2.  RESEARCH SUPPLEMENTS FOR UNDERREPRESENTED MINORITY UNDERGRADUATE
STUDENTS

DESCRIPTION

This supplemental program provides an opportunity for minority
undergraduate students interested in biomedical or behavioral
research to participate in a research project at a research
institution during the summer months or during the school year.  This
experience will be separate from any requirement of the regular
academic program.

ELIGIBILITY

The student may be affiliated with either the applicant institution
or another academic institution.  Any undergraduate minority student
interested in biomedical or behavioral research is encouraged to
participate in this program.

PROVISIONS

This supplement  generally should not exceed $6.00 per hour for
salary plus $125 per month for supplies and travel.  Institutional
rates for undergraduate salary which exceed $6.00 per hour must be
strongly justified.  Equipment may not be purchased from these funds.
Students are expected to devote the equivalent of at least three
months full-time effort to the research project and related
activities in any one year and, in most cases, the period of support
for any individual should last at least two years.  Exceptions to
these requirements will be considered, depending on the circumstances
of the applicant, the parent grant, and the specific request.

See the GENERAL PROVISIONS section for information about application
procedures, review criteria, and funding.

3.  RESEARCH SUPPLEMENTS FOR UNDERREPRESENTED MINORITY GRADUATE
RESEARCH ASSISTANTS

DESCRIPTION

The objective of this program is to reach out to minority graduate
students already in biomedical and behavioral sciences and provide an
opportunity to further develop their research capabilities.

ELIGIBILITY

Any minority graduate student who is enrolled in a masters or a
doctoral degree program in biomedical or behavioral sciences is
eligible for consideration.  Students enrolled in a masters degree
program in nursing sciences or social work may also be eligible.
Minority students in medical school are encouraged to use this
program to gain research experience.

PROVISIONS

The NIH will provide salary support in addition to other necessary
expenses, such as supplies and travel, to enable the individual to
participate as a graduate research assistant in funded research
projects.  As in the past, the NIH will continue to consider the
compensation for the personal services of graduate students and other
employees rendered to an NIH research project to be allowable as long
as the compensation is reasonable and (1) conforms to the
established, consistently applied salary and wage policies of the
institution and (2) reflects the percentage of time actually devoted
to the PHS-funded project.  For graduate students this compensation
may include tuition remission paid as, or in lieu of, wages provided
that, the student is in a bona fide employer-employee relationship
with the institution for the work performed, and payment is
conditioned explicitly on the performance of necessary work.
Reasonable compensation for graduate students must not exceed the
amount allowable for a first year postdoctoral level staff member, at
the same institution, performing comparable work.  Additional funds
up to $3000 per year may be requested for supplies and travel.  Funds
may not be used to purchase equipment.

See the GENERAL PROVISIONS section for information about application
procedures, review criteria, and funding.

4.  RESEARCH SUPPLEMENTS FOR UNDERREPRESENTED MINORITY INDIVIDUALS IN
POSTDOCTORAL TRAINING

DESCRIPTION

These supplements provide research support to permit minority
individuals in the postdoctoral phase of their training to
participate in ongoing research projects as a means of assisting them
in their development into independent biomedical or behavioral
researchers.  Toward the end of the supplement award, candidates
should be encouraged to apply for fellowships, FIRST awards, and
other sources of independent support.

ELIGIBILITY

The minority individual in postdoctoral training may be affiliated
with either the applicant institution or some other institution.
Only under extraordinary circumstances, which must be well justified
in the application, would it be acceptable for the postdoctoral
candidate to work with his or her former predoctoral mentor.

PROVISIONS

The NIH will provide support for  salary in addition to other
necessary expenses, such as travel and supplies, to enable the
minority individual to participate as a postdoctoral research
assistant or associate on the funded research project.  The requested
salary must be in accordance with the salary structure of the grantee
institution and consistent with the level of effort.  Additional
funds, up to $6000, may be requested for supplies and travel.
Support may not be used to purchase equipment.

See the GENERAL PROVISIONS section for application procedures, review
criteria and funding.

5.  RESEARCH SUPPLEMENTS FOR UNDERREPRESENTED MINORITY INVESTIGATORS

DESCRIPTION

These supplements provide either short- or long-term research support
for minority staff or faculty members to enhance their research
skills leading to an independent research career.

o  Short-term Minority Investigator Research Supplement.  This
supplement provides short-term support for minority staff or faculty
members to conduct full-time research for three to five months each
year during the summer or another portion of the academic year, over
a maximum period of four years.

o  Long-term Minority Investigator Research Supplement.  This
supplement provides long-term research support for minority staff or
faculty members to conduct research in the biomedical or behavioral
sciences.  Support is provided for up to four years at a minimum of
30 percent effort during each 12-month period.

ELIGIBILITY

The minority investigator may be affiliated with the applicant
institution or some other institution.  The investigator must have a

From owner-sci-resources@net.bio.net Sat Feb 17 22:00:00 1996
Path: biosci!biosci!not-for-mail
From: BIOSCI Administrator <biosci-help@net.bio.net>
Newsgroups: bionet.sci-resources
Subject: NIH GUIDE - PA-96-022 - V25(03) 02/09/96
Date: 18 Feb 1996 14:29:51 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 473
Sender: daemon@net.bio.net
Approved: biosci-help@net.bio.net
Distribution: world
Message-ID: <4g898v$cli@net.bio.net>
NNTP-Posting-Host: net.bio.net

$$XID RFA PA96022 PA-96-022 P1O1 ***************************************

HUMAN MODELS AND MARKERS OF SKELETAL AGING

NIH GUIDE, Volume 25, Number 3, February 9, 1996

PA NUMBER:  PA-96-022

P.T. 34; K.W. 0755020, 0710010, 0715031

National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Dental Research
National Institute of Diabetes and Digestive and Kidney Diseases

PURPOSE

The National Institute on Aging (NIA), the National Institute of
Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National
Institute of Dental Research (NIDR) and the National Institute of
Diabetes and Digestive and Kidney Diseases (NIDDK) invite research
grant applications to develop or refine models and markers using
human bone, bone marrow or bone cell constituents which more
accurately reflect those age-related and/or pathophysiological
processes occurring within the mature human skeleton that lead to
osteoporosis and other age-related skeletal diseases. It is expected
that improved human models and markers of age-related changes in
skeletal tissue structure and function will enhance the accuracy and
reliability of diagnostic and prognostic capabilities and serve to
expedite the development of more effective, targeted preventive and
therapeutic strategies.

Model development and refinement should be conducted from the
perspective of facilitating a) the identification of better
prognostic indicators of the occurrence, progression, cessation or
reversal of skeletal involution (due to aging, menopause, age-
related morbidity, drugs); b) the identification of age-related
pathologies/co-morbidities contributing to compromises in peripheral,
axial and craniofacial skeletal integrity; c) the prediction of
response or non-response to various therapeutic agents and/or d)
further epidemiologic studies of risk factors for age-related bone
disease and bone loss and fracture outcomes.

HEALTHY PEOPLE 2000

The Public Health Service (PHS) is committed to achieving the health
promotion and disease prevention objectives of "Healthy People 2000,"
a PHS-led national activity for setting priority areas.  This PA,
Human Models and Markers of Skeletal Aging is related to the priority
area of osteoporosis.  Potential applicants may obtain a copy of
"Healthy People 2000" (Full Report:  Stock No. 017-001-00474-0) or
"Healthy People 2000" (Summary Report:  Stock No. 017-001-00473-1)
through the Superintendent of Documents, Government Printing Office,
Washington, DC 20402-9325 (telephone 202-783-3238).

ELIGIBILITY REQUIREMENTS

Applications may be submitted by domestic and foreign, for-profit and
non-profit organizations, public and private, such as universities,
colleges, hospitals, laboratories, units of State and local
governments, and eligible agencies of the Federal government.
Applications may  be submitted by single institutions or by a
consortia of institutions.  Foreign institutions are not eligible for
First Independent Research and Support and Transition (FIRST) awards
(R29), but may submit applications for individual research project
grants (R01): foreign applicants may also participate in laboratory
or clinical programs through subcontract or consortium arrangements.
Racial/ethnic minority individuals, women, and persons with
disabilities are encouraged to apply as Principal Investigators.

Applicants from institutions that have a General Clinical Research
Center (GCRC) funded by the NIH National Center for Research
Resources may wish to identify the GCRC as a resource for conducting
the proposed research.  If so, a letter of agreement from either the
GCRC Program Director or Principal Investigator should be included
with the application.

MECHANISM OF SUPPORT

This program announcement will use the NIH investigator-initiated
research project grant (R01) and FIRST (R29) award mechanisms. It is
anticipated that the size of an award will vary due to the nature and
scope of the proposed research, with the R01 award ranging from
$150,000 to $500,000 in total (direct plus indirect) costs per year.

FUNDS AVAILABLE

Approximately $900,000 from NIA and up to $500,000 from NIAMS in
total costs for the first year of funding will be made available in
Fiscal Year 1997 to specifically fund applications submitted in
response to this PA for the February/March 1996, June/July 1996 and
October/November 1996 application receipt deadlines.  An additional
$300,000 from NIA and $200,000 from NIAMS will be made available in
Fiscal Year 1998 to fund applications for this PA which are submitted
by the February/March 1997 deadline.  NIDR maintains a special
interest in research focused on oral/craniofacial hard tissues,
including related model systems and intends to fund 2-4 additional
high quality applications in FY 1997.  NIDDK also maintains an active
interest in research questions related to the hormonal regulation of
bone in health and disease and anticipates funding of 2-3 additional
applications as funds warrant in FY97.  This funding level is
dependent on the receipt of a sufficient number of applications of
high scientific merit.  Although this program is provided for in the
financial plans of the NIA, NIAMS, NIDR and NIDDK, the award of
grants pursuant to this PA is contingent upon the availability of
funds at the time the awards are made.

RESEARCH OBJECTIVES

Background

Our ability to predict, prevent, slow or reverse age-related bone
loss and bone diseases such as osteoporosis is limited because so few
studies have focused on cells and skeletal tissue from the aging
human skeleton.  Although osteoporosis and age-related diseases such
as Paget's disease occur primarily in the mature, aging human
skeleton, in vitro models used to study bone biology have consisted
primarily of transformed cell lines from human or rodent
osteosarcomas, or cell systems derived from fetal or neonatal rodent
bone.  In addition to marked differences in the chemical composition
and macro- and microarchitectural organization of bone, other
anomalies imposed by current models that reflect inappropriate age,
species and other phenotypic characteristics limit the
generalizability of putative biological mechanisms to those occurring
in the human skeleton.

Appropriate model systems are needed to develop markers that are more
sensitive and specific in predicting changes in bone mass, bone
competence and fracture susceptibility.  Significant improvements in
techniques to assess the status of bone cell activity in the skeleton
are necessary to provide answers to key clinical questions such as 1)
is a given individual currently losing bone?, 2) by which mechanisms
is bone being lost?  3) at what anatomic site/compartment(s) is bone
being lost?, 4) at what rate is bone being lost?, 5) is a promising
new treatment likely to be effective, and if so, for which patients
and 6) if a treatment is initially effective, for how long will it
continue to be effective?

Models and markers which better reflect the proliferative capability,
differentiated function and qualitative features of bone cells in the
mature human skeleton will facilitate improved techniques to assess
the cellular and metabolic status of skeletal tissue.  Such advances
will further enhance the accuracy of diagnoses, prognoses and
decision-making with respect to available and future treatment
options and also facilitate the evaluation and targeting of potential
new therapies (based on an understanding of how responses to these
therapies are modified by age, gender, genetics and ethnicity).  The
acceleration of advances in bone biology and related fields as well
as the development of many new promising technologies (such as
transgenic animal models, in situ hybridization, immunocytochemistry
and reverse transcriptase polymerase chain reaction (RT-PCR) in
conjunction with histomorphometric, densitometric, qualitative, etc.
techniques) provide improved capabilities to address these problems.

A Workshop on Human Models of Skeletal Aging was organized and
sponsored by the NIA and the NIDR in Washington, D.C., on March 1-2,
1994.  Its objective was to address methodological issues integral to
facilitating clinically relevant studies on the causes and
consequences of bone loss and osteoporosis at the cellular and tissue
levels in the aging human skeleton.  The proceedings of this Workshop
have been published [Calcif Tissue Int (1995) 56(Suppl 1); pp S1-S56;
eds., Gehron Robey P and Sherman S].

Research Goals and Scope

The purpose of this initiative is to stimulate studies to develop or
refine and validate models and markers which more accurately reflect
processes mediating aging or age-related skeletal diseases of the
axial, peripheral and craniofacial skeleton, such as osteoporosis.

Research applications submitted in response to this PA must combine
all three of the following components in the research plan proposed
for the project period of the application (maximum five years):

1.  Development of model systems for human skeletal aging and
age-related disease, using human bone, bone marrow or other bone cell
constituents.

2.  Use of these model systems to define new markers for diagnosis
and/or prognosis of age-related physiologic and pathologic changes,
and/or prediction of responsiveness to specific therapies AND,

3.  Validation of these models and markers against in vivo parameters
of skeletal status such as changes in bone mass, bone strength,
architecture, histomorphometric indices of bone turnover, or the
occurrence of fractures.

The validation of models and markers against in vivo parameters of
skeletal status is a required component for projects submitted in
response to this PA.  The validation component must include a plan to
determine the extent to which proposed models and markers reflect
changes due to age and/or age-related skeletal disease. Validation of
markers should also include an assessment of their sensitivity,
specificity, intra- and inter-individual variability (including
effects of age, gender, and ethnicity).

Types of models and markers that might be developed include, but are
not limited to:

o  Models of mature osteoblast, osteoclast, osteocyte, and bone
lining cell function

o  Models of osteoprogenitor cell recruitment, proliferation,
differentiation and function o  Validated peripheral blood cell
models (e.g. monocytes, CD 34+ cells) of osteoclast or
osteoclast-like function

o  Markers of bone cell phenotype and stage of differentiation

o  Models that reflect embryonic origin (e.g., neuroectoderm versus
mesoderm)

o  Models using bone from multiple anatomic (peripheral, axial and
craniofacial) sites, and different types of bone, bone matrix, bone
marrow and other cellular constituents; development of techniques
requiring minimal amounts of skeletal material or constituents

o  Models derived from or synthesizing lamellar bone (of cortical or
trabecular origin)

o  Models that can reconstitute the "BMU" (basic multicellular unit)
which contains osteocytes, lining cells, osteoblasts, osteoclasts,
vascular components, etc.

In vivo parameters that could be used to validate these models and
markers include but are not limited to:

o  In vivo responses of bone (changes in bone mass, strength, etc) to
regulatory factors (hormones, cytokines, etc.) and pharmacologic
agents (measured by existing or new imaging techniques)

o  Bone cell or bone marrow progenitor proliferative capacity,
morphology, surface markers, gene expression, and/or expression of
differentiated function

o  Rates of bone formation and bone resorption (e.g., using
histomorphometric techniques)

o  In vivo/in vitro or in situ spatial organization of cells and
temporal sequence of events during the bone remodelling process

o  Qualitative and quantitative changes in organic and inorganic
skeletal tissue components (structure, extent of mineralization,
etc.)

Because age-related bone loss and osteoporosis are heterogeneous and
multifactorial in nature, applicants are encouraged to adopt
interdisciplinary approaches, establishing or strengthening
interactions and integration of efforts between clinical and basic
science investigators.  Research teams should include, where
possible, a diverse range of expertise in areas such as bone biology,
molecular biology, bone densitometry, orthopedics, histomorphometry,
endocrinology, geriatrics, epidemiology and biostatistics.

Because the current state of knowledge on skeletal aging and
therapeutics in men is extremely limited, research proposing to
include men (as well as women) as participants is strongly
encouraged.

In their application(s), applicants are encouraged to request funds
for one to two participants to meet annually in Bethesda, Maryland
with investigators of similar projects.  Program directors from
participating institutes will coordinate these meetings which will
provide the opportunity for principal investigators to share
findings, discuss their work in progress and to raise cross-cutting
methodological and scientific issues.

INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN
SUBJECTS

It is the policy of the NIH that women and members of minority groups
and their sub-populations must be included in all NIH supported
biomedical and behavioral research projects involving human subjects,
unless a clear and compelling rationale and justification is provided
that inclusion is inappropriate with respect to the health of the
subjects or the purpose of the research.  This new policy results
>From the NIH Revitalization Act of 1993 (Section 492B of Public Law
103-43) and supersedes and strengthens the previous policies
(Concerning the Inclusion of Women in Study Populations, and
Concerning the Inclusion of Minorities in Study Populations), which
have been in effect since 1990. The new policy contains some
provisions that are substantially different from the 1990 policies.

All investigators proposing research involving human subjects should
read the "NIH Guidelines For Inclusion of Women and Minorities as
Subjects in Clinical Research," which have been published in the
Federal Register of March 20, 1994 (FR 59 14508-14513) and reprinted
in the NIH Guide for Grants and Contracts, Volume 23, Number 11,
March 18, 1994.

Investigators also may obtain copies of the policy from the program
staff listed under INQUIRIES.  Program staff may also provide
additional relevant information concerning the policy.

APPLICATION PROCEDURES

Applications are to be submitted on the grant application form PHS
398 (rev. 5/95) and will be accepted at the standard application
deadlines as indicated in the application kit.  Applications kits are
available at most institutional offices of sponsored research and may
be obtained from the Grants Information Office, Office of Extramural
Outreach and Information Resources, National Institutes of Health,
6701 Rockledge Drive, MSC 7910, Bethesda, MD 20892-7910, telephone
301/435-0714, email:  girg@drgpo.drg.nih.gov.  The title and number
of this program announcement must be typed in Section 2 on the face
page of the application.

Applications for the FIRST (R29) award must include at least three
sealed letters of reference attached to the face page of the original
application.  FIRST (R29) award applications submitted without the
required number of reference letters will be considered incomplete
and will be returned without review.

The completed original application and five legible copies must be
sent or delivered to:

DIVISION OF RESEARCH GRANTS
NATIONAL INSTITUTES OF HEALTH
6701 ROCKLEDGE DRIVE, ROOM 1040 - MSC 7710
BETHESDA, MD 20892-7710
BETHESDA, MD 20817-7710 (for express/courier service)

REVIEW CONSIDERATIONS

Applications will be assigned on the basis of established Public
Health Service referral guidelines.  Applications that are complete
will be evaluated for scientific and technical merit by an
appropriate peer review group convened in accordance with the
standard NIH peer review procedures.  As part of the initial merit
review, all applications will receive a written critique and undergo
a process in which only those applications deemed to have the highest
scientific merit, generally the top half of applications under
review, will be discussed, assigned a priority score, and receive a
second level review by the appropriate national advisory council.
The review criteria to be used in the evaluation of applications
submitted in response to this program announcement are:

o  Scientific, technical, or medical significance and originality of
proposed research;

o  Appropriateness and adequacy of the experimental approach and
methodology proposed to carry out the research;

o  Inclusion of all three required research components described
under Research Goals and Scope

o  Qualifications and research experience of the Principal
Investigator and staff, particularly, but not exclusively, in the
area of the proposed research;

o  Availability of the resources necessary to perform the research;

o  Appropriateness of the proposed budget and duration in relation to
the proposed research;

o  Adequacy of the provisions for the protection human subjects and
safety of the research environment; and

o  Adequacy of plans to include both genders and minorities and their
subgroups as appropriate for the scientific goals of the research.
Plans for the recruitment and retention of subjects will also be
evaluated.

AWARD CRITERIA

Applications will compete for available funds with all other approved
applications assigned to that IC.  The following will be considered
in making funding decisions:

o Quality of the proposed project as determined by peer review;

o Availability of funds; and

o Program priority.

INQUIRIES

Inquiries concerning this PA are encouraged.  The opportunity to
clarify any issues or questions from potential applicants is welcome.

Direct inquiries regarding programmatic issues to:

Sherry Sherman, Ph.D.
Geriatrics Program
National Institute on Aging
Gateway Building, Suite 3E327
7201 Wisconsin Avenue, MSC 9205
Bethesda, MD  20892-9205
Telephone:  (301) 496-1033
FAX:  (301) 402-1784
Email: ShermanS@gw.nia.nih.gov

Joan A. McGowan, Ph.D.
Bone Diseases Program
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Natcher Building, Room 5AS-43E
45 Center Drive, MSC 6500
Bethesda, MD  20892-6500
Telephone:  (301) 594-5055
FAX:  (301) 480-4543
Email:  mcgowanj@ep.niams.nih.gov

Joseph E. Ciardi, Ph.D.
Craniofacial Development and Disorders Program
National Institute of Dental Research
Natcher Building, Room 4AN-24E
45 Center Drive, MSC 6402
Bethesda, MD  20892-6402
Telephone:  (301) 594-2337
FAX:  (301) 480-8318
EMail:  ciardiJ@de45.nidr.nih.gov

Ronald Margolis, Ph.D.
Division of Diabetes, Endocrinology and Metabolic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
45 Center Drive, Room 5AN-12J, MSC 6600
Bethesda, MD  20892-6600
Telephone:  (301) 594-8819
FAX:  (301) 480-3503
Email:  rm76f@nih.gov

Direct inquiries regarding fiscal matters to:

Mr. Joseph Ellis
Grants and Contracts Management Office
National Institute on Aging
Gateway Building, Suite 2N212
7201 Wisconsin Avenue, MSC 9205
Bethesda, MD  20892-9205
Telephone:  (301) 496-1472
FAX:  (301) 402-3672
Email: EllisJ@gw.nia.nih.gov

Ms. Vicki Maurer
Grants Management Office
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Natcher Building, Room 5AS-49A
45 Center Drive, MSC 6500
Bethesda, MD  20892-6500
Telephone:  (301) 594-3504
FAX:  (301) 480-5450
Email:  maurerv@ep.niams.nih.gov

Mr. Martin R. Rubinstein
Grants Management Office
National Institute of Dental Research
Natcher Building, room 4AN-44A
45 Center Drive MSC 6402
Bethesda, MD  20892-6402
Telephone:  (301) 594-4800
FAX:  (301) 480-8308
Email:  Martin.Rubinstein@NIH.GOV

AUTHORITY AND REGULATIONS

This program is described in the Catalog of Federal Domestic
Assistance Nos. 93.866, 93.846, 93.847 and 93.121. Awards are made
under authorization of the Public Health Service Act, Title IV, Part
A (Public Law 78-410, as amended by Public Law 99-158, 42 USC 241 and
285) and administered under PHS grants policies and Federal
Regulations 42 CFR 52 and 45 CFR Part 74.  This program is not
subject to the intergovernmental review requirements of Executive
Order 12372 or Health Systems Agency review.

The PHS strongly encourages all grant recipients to provide a
smoke-free workplace and promote the non-use of all tobacco products.
In addition, Public Law 103-227, the Pro-Children Act of 1994,
prohibits smoking in certain facilities (or in some cases, any
portion of a facility) in which regular or routine education,
library, day care, health care or early childhood development
services are provided to children.  This is consistent with the PHS
mission to protect and advance the physical and mental health of the
American people.

From owner-sci-resources@net.bio.net Sat Feb 17 22:00:00 1996
Path: biosci!biosci!not-for-mail
From: BIOSCI Administrator <biosci-help@net.bio.net>
Newsgroups: bionet.sci-resources
Subject: NIH GUIDE - RFA ES-96-004 - V25(03) 02/09/96
Date: 18 Feb 1996 14:29:23 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 390
Sender: daemon@net.bio.net
Approved: biosci-help@net.bio.net
Distribution: world
Message-ID: <4g8983$cgr@net.bio.net>
NNTP-Posting-Host: net.bio.net

$$XID RFA ES96004 ES-96-004 P1O1 ***************************************

LINKING OF ENVIRONMENTAL AGENTS AND DISEASE

NIH GUIDE, Volume 25, Number 3, February 9, 1996

RFA:  ES-96-004

P.T. 34; K.W. 1007001, 0705048

National Institute of Environmental Health Sciences

Letter of Intent Receipt Date:  April 5, 1996
Application Receipt Date:  May 8, 1996

PURPOSE

The National Institute of Environmental Health Sciences (NIEHS)
supports research to identify the role of environmental agents in
perturbations of normal physiologic processes leading to human
disease.  Although direct links between environmental agents and
health outcomes have been established for some diseases, there are
numerous chronic dysfunctions and diseases where there are minimal
scientific data to substantiate a role for the environment in their
etiology or progression, despite the plausibility of these
hypotheses.  Therefore, the goal of this Small Grants Program (R03),
Request for Applications (RFA) is to encourage research that will
establish whether there is sufficient evidence either mechanistically
or from epidemiologic studies to justify further investigations into
the role of environmental agents in the initiation or exacerbation of
human diseases.  Research is specifically encouraged to determine the
sound scientific connection between environmental agent and the
initiation or progression of disease.

HEALTHY PEOPLE 2000

The Public Health Service (PHS) is committed to achieving the health
promotion and disease prevention objectives of "Healthy People 2000,"
a PHS-led national activity for setting priority areas.  This RFA,
Linking of Environmental Agents and Disease, is related to the
priority area of environmental health.  Potential applicants may
obtain a copy of "Healthy People 2000: (Full Report:  Stock no.
017-001-00474-0 or Summary Report:  Stock No. 017-001-00473-1)
through the Superintendent of Documents, Government Printing Office,
Washington, DC 20402-9325 (telephone: (202) 512-1800).

ELIGIBILITY REQUIREMENTS

Applications may be submitted by domestic, for-profit and non-profit
organizations, public and private, such as universities, colleges,
hospitals, laboratories, units of State or local governments and
eligible agencies of the Federal government.  Foreign institutions
and organizations are not eligible.  Applications from minority
individuals and women are encouraged.  Submission of an application
precludes concurrent submission of a regular research projfect grant
application (R01 or R29) containing the same research proposal.  In
addition, small grant research support may not be used to supplement
research projects currently supported by Federal or non-Federal funds
or to provide interim support for projects under review by the Public
Health Service.

MECHANISM OF SUPPORT

This RFA will use the NIH Small Grants Program (R03) awards.
Responsibility for the planning, direction, and execution of the
proposed project will be solely that of the applicant.  The requested
costs and project period will be $50,000 (direct cost) for a maximum
of one year.  Small grants are not renewable but may be extended at
the discretion of the applicant organization.

FUNDS AVAILABLE

The total estimated funds available for this small grants program is
$750,000 which will support approximately 10
to 12 awards.  This level of support is dependent on the receipt of
sufficient number of applications of high scientific merit.  Although
this program is provided for within the financial plans of the NIEHS,
awards pursuant to this RFA are contingent upon the availability of
funds for this purpose.

RESEARCH OBJECTIVES

Objectives and Scope

A major goal of the NIEHS is to improve our understanding of the
contribution of environmental factors to the development of disease.
In order for NIEHS to successfully carry out this mission, it is
imperative to have information on the role of the environment in a
wide variety of disease states.  Preliminary data are needed to
foster the development of  mechanistically-based research on the
relationship between environmental agents and diseases.  This RFA is
designed specifically to develop preliminary data on the possible
role of the environment in diseases in which links to exposure are
suggested but remain unproven.  It is anticipated that these
preliminary data will support development of hypothesis-based
research to establish the cause and effect relationship between
environmental exposures and disease etiology.

Research Goals

The goals and scope of the RFA are two-fold. The first is to
encourage and support mechanistically-based research designed to
establish the linkage between exposure to an environmental agent,
tested at environmentally relevant concentrations, and the initiation
or exacerbation of diseases.  The second area of emphasis is to
utilize human populations studies to develop hypotheses relating
environmental exposure to the initiation or exacerbation of diseases.
In either situation, emphasis should be placed on developing the
preliminary data that would lead to the development of an R01 or R29
application.

The role of environmental agents in disease may be approached using
animal models, human tissue/cell-lines or human epidemiologic
studies.  In any case, environmentally relevant concentrations using
dose-response data is encouraged.  The effect of age and the timing
of exposure relative to the toxicity or effect should also be
included as part of the experimental design.

The purpose of this RFA is to expand data on non-cancer diseases.
Therefore, research on the role of environmental agents in the
initiation or exacerbation of cancers of any type will be considered
nonresponsive.

SPECIAL REQUIREMENTS

Animal Welfare Considerations

Investigators are encouraged to consider alternative methods and
approaches in their research applications that do not require the use
of whole animals, that use alternative species such as nonmammals or
invertebrates, that reduce the number of animals required, and that
incorporate refinements to procedures that will result in the
elimination or further minimization of pain and distress to animals.

INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN
SUBJECTS

It is the policy of the NIH that women and members of minority groups
and their subpopulations must be included in all NIH supported
biomedical and behavioral research projects involving human subjects,
unless a clear and compelling rationale and justification is provided
that inclusion is inappropriate with respect to the health of the
subjects or the purpose of the research. This new policy results from
the NIH Revitalization Act of 1993 (Section 492B of Public Law 103
43) and supersedes and strengthens the previous policies (Concerning
the Inclusion of Women in Study Populations, and Concerning the
Inclusion of Minorities in Study Populations), which have been in
effect since 1990.  The new policy contains some provisions that are
substantially different from the 1990 policies.

All investigators proposing research involving human subjects should
read the NIH Guidelines for Inclusion of Women and Minorities as
Subjects in Clinical Research, which have been published in the
Federal Register of March 28, 1994 (FR 58 14508-14513) and reprinted
in the NIH Guide for Grants and Contracts, Volume 23, Number 11,
March 18, 1994.

Investigators also may obtain copies of the policy from the program
staff listed under INQUIRIES.  Program staff may also provide
additional relevant information concerning the policy.

LETTER OF INTENT

Prospective applicants are asked to submit, by April 5, 1996, a
letter of intent that includes a descriptive title of the proposed
research, the name, address and telephone number of the Principal
Investigator, the identities of other key personnel and consultants,
the participating institutions, and the number and title of the RFA
in response to which the application may be submitted.  Although a
letter of intent is not required, is not binding, and does not enter
into the review of subsequent application, the information that it
contains is helpful in planning for the review of applications.  It
allows NIEHS staff to estimate the potential review work load and to
avoid conflict of interest in the review.

The letter of intent is to be sent to:

Ethel B. Jackson, D.D.S.
Extramural Division
National Institute of Environmental Health Sciences
P.O. Box 12233, MD 17-09
104 T.W. Alexander Drive, Building 17, Room 1717
Research Triangle Park, NC  27709
Telephone:  (919) 541-7826
FAX:  (919) 541-2503
EMAIL:  jackson4@niehs.nih.gov

APPLICATION PROCEDURES

The research grant application form PHS 398 (rev. 5/95) is to be used
in applying for these grants.  These forms are available at most
institutional offices of sponsored research and may be obtained from
the Grants Information Office, Office of Extramural Outreach and
Information Resources, National Institutes of Health, 6701 Rockledge
Drive, MSC 7910, Bethesda, MD 20892-7910, telephone 301/435-0715,
email:  girg@drgpo.drg.nih.gov.

The following supplemental instructions are given:

Only one small grant application may be submitted by a principal
investigator.

Due to the limited size of awards, no specific budget categories and
percent efforts will be required.  This will be a $50,000 award -
direct cost.  Equipment will be limited to $5,000.

The applicant must be explicit in describing the proposed interface
between an environmentally relevant agent and the induction or
exacerbation of a specific disease.  Background information must
suggest, or at least not preclude, a possible interaction between
these parameters.

Since this award is to support pilot studies, preliminary data are
not required except to indicate the expertise of the PI to carry out
the proposed studies.

The Research Plan (Specific Aims, Background and Significance,
Preliminary Studies, Research Design and Methods sections) is not to
exceed 10 pages.  Tables and figures are included in the 10 page
limitation.  Applications that exceed page limitations or PHS 398
requirements for font size (height or letters), type density
(characters per inch), and margins (see PHS 398 directions) will be
returned to the investigator.

Do not submit an appendix.

The RFA Label available in the PHS 398 (rev. 5/95) application form
must be affixed to the bottom of the face page of the application.
Failure to use this label could result in delayed processing of the
a